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Preface 
  
 This book is aimed to be a guide of scientific writing for researchers and graduate 
students in the biomedical sciences. The approach of the book is strictly practical as it 
follows an authentic example article section by section focusing on the special organi-
zation of each part of the paper including the appropriate use of the tenses of verbs. It 
likewise contains words and phrases, which may create problem at least to those not 
native in the English language. The book also guides readers to the secrets of editorial 
correspondence and editorial processes and contains tips on statistical analyses in the 
form of simple examples. The last parts of the book deal with the preparation of a 
successful grant proposal and the ethics of the research. 
 The book is mainly aimed at graduate students preparing their first scientific pa-
pers but it may be useful also for more experienced scientists, who may, to their sur-
prise, find that scientific writing includes distinct rules and technical formalities. 
 The book is mainly based on the lectures of the author given over the past several 
years at the University of Kuopio. It is the impression of the author that there is a need 
for this kind of practical guide. 
 I thank Professors Leena Alhonen and Garry Wong for their extremely helpful 
comments. Garry Wong also kindly revised the English language. The American So-
ciety for Biochemistry and Molecular Biology kindly granted permission to use the 
example article in the book. 
 
Kuopio, 2005           Juhani Jänne 
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1. History of the scientific article 
 
 The publication of the first scientific series (Philosophical Transactions, London) 
started already more than 300 years ago. The first publications only remotely resem-
bled the present-day scientific articles being informal and descriptive, sort of “case 
reports”. The modern scientific paper started to develop at the turn of the 20th century 
when distinct rules were introduced to define the structure and organization of differ-
ent parts of the article. This was the emergence of the so-called IMRAD format that is 
exclusively used in all current scientific journals. 
 
2. IMRAD format as the backbone of a scientific paper 
 
 IMRAD format (the abbreviation stands for I, Introduction; M, Methods; R, Re-
sults; And D, Discussion) has been developed during the last 100 years and it is today 
exclusively used by all scientific journals. Even though the recommendation to use 
the IMRAD format in scientific writing was introduced already at the turn of the 20th 
century, the scientific journals only slowly adopted the format in the 1970´s when 
about 80 % of articles in medical journals adhered to the IMRAD format. Apparently, 
the basic science journals adopted the format much earlier, in the late 50´s and 60´s. A 
few current journals follow a slightly different IRDAM format, in which the Methods 
are described in the last section of the paper. 
 
IMRAD logic: 
< What was the problem studied? Answer = Introduction 
< How was it studied?                     Answer = Methods 
< What were the results?                Answer = Results 
<                                                                          And 
<  What do the results mean?         Answer = Discussion  
 
 The IMRAD format established fixed rules for scientific writing even determining 
the tense of the verbs (past or present) in a given section of the paper. The format not 
only gives rules for the writing, it also makes the reading of the paper easier as given 
items can be found in particular sections. The format likewise facilitates the peer re-
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view process. Although the format lacks the acronym for Abstract, also the abstract 
itself is structured according to IMRAD. The use of the format is not confined to pri-
mary publications as it is also used in posters, verbal presentations and, to some ex-
tent, even in medical case reports. 
 
3. Writing as a part of the internal scientific process 
 
 An individual scientist and scientific article belong to a network where journal 
editors and independent reviewers act as major players. At best, the scientific publica-
tion is included in textbooks after being assessed by the scientific community (Fig. 1). 
                               Fig. 1. Individual scientist and the internal 
                                          scientific process 
 
 How important is publishing? The unambiguous answer is: Research, independent 
of how revolutionary it is, is nothing until published. Robert A. Day compares in his 
book (see chapter 14) scientific research with the fall of a tree in the forest: “If a tree 
falls in the forest and there is no one to hear it falling, does it make a sound? The cor-
rect answer is no. Sound is more than pressure waves, and indeed there will be no 
sound without a hearer.” The saying “Publish or perish” most accurately describes 
the importance of publishing in our current scientific community. 
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4. Writing a scientific paper 
 
 Good scientific writing probably requires more organizational than literary skills, 
yet the latter gift certainly is not a disadvantage. 
 
4.1. Preparatory work before you start writing 
 Careful preparation for the final writing makes the whole process a lot easier. The 
preparatory work includes the collection and organization of the experimental mate-
rial, such as the composition of tables and design of the layout of the figures. At this 
stage, the data have been analyzed and the statistical analyses have been carried out. 
The illustrative material (tables and figures) is arranged according to their order of 
presentation. There may be tables, the content of which is presented in the text (e.g. 
negative results) instead of formal tables. Fig. 2 depicts an example of the outlining of 
the structure and content of the paper before writing. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Outlining of the structure and content 
                     of a paper before writing. 
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 It is of paramount importance to become familiar with the instructions to authors 
of the selected journal and to carefully follow them (appearance of the references in 
the text, the style of headings and subheadings, the style of figure legends and table 
captions etc). A copy of a recent article published in the selected journal greatly helps 
to properly organize the paper. The instructions should be followed from the very first 
draft. Those who are not native in English language are strongly advised to write in 
English (see also the differences between British and American English) from the be-
ginning and not to translate the manuscript afterwards. At this stage, things, such as 
the title (Fig.2) may change. 
 When the writing is outlined, a descriptive name in the form of a single sentence 
may be given to each figure and table. By reading these few sentences, the main mes-
sage of the manuscript should become evident. Even a scientist thinks narratively. 
Science is a story to be told. Give your paper a narrative structure that links one find-
ing to another and describes why certain experiments were performed in response to 
the results of another experiment. 
 
4.2. Title and authors 
 The title should describe the main content of the paper as well as possible and 
should not to be too general or specific. The title should likewise be attractive as thou-
sands read the title, a few, possibly no one, the whole article. The title is not a sen-
tence and hence the verb is often unnecessary. It is advisable to get familiar with the 
title styles of the selected journal. Some journals apparently dislike “categorical” ti-
tles, such as “The cause of X is Y”. Some journals do not like hanging titles. One dis-
advantage of the hanging titles is also the fact that the last part of the tile may be lost 
upon citation. The title should be prepared already before the start of writing as it in-
fluences the presentation of the data. A short title (running title) with a defined maxi-
mum number of characters (usually 60) is often required and should be prepared al-
ready at this stage as it should condense the essential message of the title. Most of the 
journals require 5 to 6 key words that do not appear in the title. Some journals require 
the key words in so-called MeSH (Medical Subject Headings) format. These can be 
easily obtained from the PubMed database; type your keywords for search and click 
“details” to get the words in MeSH format. One should be careful with the syntax of 
the title. There are a vast number of examples of titles in the literature, which are 
rather humoristic due to syntax errors. The following title with faulty order of words 
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actually means that virus has created mice: “Mechanism of suppression of pneumonia 
in mice induced by virus.” It should read: “Mechanism of suppression of pneumonia 
induced in mice by virus.” The use of dangling participles entirely changes the mean-
ing of the following title indicating that bacteria cause mastitis by gas-liquid chroma-
tography: “Characterization of bacteria causing mastitis by gas-liquid chromatogra-
phy.”  
 There are no widely accepted rules to determine, who is entitled to be listed as an 
author. Every author should have a distinct contribution to the planning and execution 
of the experiments or writing or critically revising the manuscript. The following 
guideline updated in 2001 (http://www.icmje.org) by the so-called Vancouver Group 
(International Committee of Medical Journal Editors) covers very well the require-
ments for authorship. 
 
         
 
 
 
 
 
 
 
 
The last sentence of the guideline is interesting as in implies that acquisition of 
funding, collection of data or supervision of the research group do not automatically 
justify authorship.  This part of the guideline is probably most often violated upon 
preparation of the list of authors. It should also be noted that every author has to ap-
prove the final version of the manuscript. 
The order of the names in the list of authors sometimes creates problems. It is 
widely accepted (at least in biomedical journals) that the first author is a person whose 
contribution to the experiments has been most crucial. The case that two authors have 
had identical contribution can be shown: Author A* and author B* in which * refers 
to footnote “*equal contribution.” The last author usually is the leader of the research 
group proving that he/she has essentially contributed to the experiments or prepara-
tion of the manuscript. According to international practice, the list of authors is read 
Authorship credit should be based only on 
(1) substantial contributions to conception and 
design, or acquisition of data, or analysis and 
interpretation of data; (2) drafting the article 
or revising it critically for important intellectual 
content; and (3) final approval of the version to 
be published.
 
Conditions 1, 2, and 3 must all be met.
 
Acquisition of funding, the collection of data, 
or general supervision of the research group, 
by themselves, do not justify authorship. 
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into both directions: the first authors represent junior scientists and the last authors 
senior scientists. In other words, the most important authors of the publication are the 
first and last one. In most cases, the use of common sense is in order. This is exempli-
fied by the following instance of the relationship between researcher and technician. 
The researcher plans the experiments and the technician carries them out. Everything 
goes as planned: the researcher is the single author and the technician is thanked un-
der the acknowledgements. In another case, the outcome of the experiments is not as 
planned but the technician proposes changes in the experimental conditions whereaf-
ter everything works out: now the researcher is the first author and the technician is 
the second author. In many cases, an experienced technician can work as independ-
ently as a researcher and can thus be included as an author, but usually not as the first 
or last one. 
When the manuscript is sent for publication, one of the authors has to act as cor-
responding author who communicates with the editorial office of the journal. The cor-
responding author responds to editorial queries and provides additional information as 
requested. In many cases, the corresponding author can sign the copyright transfer for 
all authors, yet some journals require that each individual author must sign the trans-
fer. The contact information of the corresponding author appears in the title page of 
the manuscript, the form of which is defined in the instructions to authors of the jour-
nal. Enclosed is an example of the title page. 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A polyamine analogue prevents acute pancreatitis and
restores early liver regeneration in transgenic rats with
activated polyamine catabolism*
Tiina-Liisa Räsänen, Leena Alhonen, Riitta Sinervirta, Tuomo Keinänen, Karl-
Heinz Herzig, Suvikki Suppola, Alex R. Khomutov†, Jouko Vepsäläinen‡, a nd
Juhani Jänne§
From A.I. Virtanen Institute for Molecular Sciences, University of Kuopio, P.O. Box
1627, FIN-70211 Kuopio, Finland, †Engelhardt Institute of Molecular Biology,
Russian Academy of Sciences, Vavilov St. 32, Moscow 117984, Russia and
‡Department of Chemistry, University of Kuopio, P.O. Box 1627, FIN-70211 Kuopio,
Finland
Corresponding author: Dr. Juhani Jänne
A.I. Virtanen Institute for Molecular Sciences
University of Kuopio
P.O. Box 1627
FIN-70211 Kuopio
Finland
Street address (for courier): Neulaniementie 2
FIN-70210 Kuopio
Finland
Phone: +358-17-163049
Fax: +358-17-163025
E-mail: Juhani.Janne@uku.fi
 12 
 Note that the contact information also contains the street address, as courier ship-
ments cannot be delivered at post office boxes. Unlike the example, most journals re-
quest the inclusion of a short (running) title and key words in the title page. 
 Enclosed is an example of the title as it appears in the Journal of Biological 
Chemistry. 
The JOURNAL OF BIOLOGICAL CHEMISTRY                         VOL 277, No. 42, Issue of October 18, pp. 39867-39872, 2002 
© 2002 by the American Society for Biochemistry and Molecular Biology, Inc.                   Printed in U.S.A. 
 
 
 
A Polyamine Analogue Prevents Acute Pancreatitis and Restores 
Early Liver Regeneration in Transgenic Rats with Activated 
Polyamine Catabolism* 
 
      Received for publication, June 17, 2002 
 Published, JBC Papers in Press, August 13, 2002, DOI 10.1074/jbc.M205967200 
 
Tiina-Liisa Räsänen, Leena Alhonen, Riitta Sinervirta, Tuomo Keinänen, Karl-
Heinz Herzig, Suvikki Suppola, Alex R. Khomutov‡, Jouko Vepsäläinen§, and 
Juhani Jänne¶ 
 
From the A.I. Virtanen Institute for Molecular Sciences and the §Department of 
Chemistry, University of Kuopio, P.O. Box 1627, FIN-70211 Kuopio, Finland and the 
‡Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Vavilov 
Street 32, Moscow 117984, Russia 
 
*This work was supported by grants from the Academy of Fin-
land. 
The costs of publication  pf this article were defrayed in part by 
the payment of page charges. This article must therefore be 
hereby marked “advertisement” in accordance with 18 U.S.C. 
Section 1734 solely to indicate this fact. 
¶ To whom correspondence should be addressed. Tel.; 358-17-
163049; Fax: 358-17-163025; E-mail: Juhani.Janne@uku.fi. 
 
 The title could also be without verb: “Prevention of acute pancreatitis and resto-
ration of early liver regeneration by a polyamine analogue in transgenic rats with 
activated polyamine catabolism.” Unlike most journals, the Journal of Biological 
Chemistry shows the funding agencies in the footnote of the title page. Most com-
monly, the grants are listed under the acknowledgments. As in this case, many jour-
nals have their own “hierarchy” for symbols. As the journal has a page charge, this is 
indicated in the footnote. The title page likewise indicates the date when the manu-
script was received for publication as well as the date of final acceptance. 
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4.3. Summary (Abstract, Synopsis) 
 It is advisable to write the first draft of the summary right after the preparation the 
title, yet it can be modified after the completion of the whole manuscript. Writing the 
summary requires a thorough acquaintance with the obtained results and an extraction 
of the most important message of the work. The summary is not a detailed description 
of the work done; use words rather than exact numbers. Usually, the summary does 
not contain references, but if needed, they should be written in full (not numbered as 
in the main body of the text). Verbs in the Summary are in past tense when one´s own 
new results are described. The overall organization of the summary adheres to the 
IMRAD format. In other words, it starts with introductory sentences (1 to 2) followed 
by the description of own results and ending with conclusions or discussion. The 
verbs in the introduction and conclusion parts of the summary are in the present tense. 
Never close the summary with a phrase like “Results will be discussed.” Practically all 
journals set a maximum length for the summary that is usually from 100 to 250 words 
(the latter is most common). The summary does not contain information or conclu-
sions that are not in the main body of the text. On the other hand, the Summary does 
not contain every result obtained. Some journals use structured summary with titles: 
Background….Methods….Results...Conclusions. Enclosed is an example of an 
authentic summary. 
 Note that the summary is clearly divided into three different parts (shown with 
E). The two first sentences represent the introduction and contain a reference that is 
written in full. The verbs are in the present tense. The introductory sentences are fol-
lowed by the description of the results and references to the used methods. Here the 
verbs are in the past tense. The last part of he the Summary represents conclusions 
and/or discussion. Here the verbs are again in the present tense. 
 The example summary contains 215 words that is less than the maximum length 
(250) defined by the journal. The condensation of the summary to the defined maxi-
mum length sometimes looks like an overwhelming task, but it almost always suc-
ceeds without compromising the essence of the message. 
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   *We recently generated a transgenic rat model for acute 
pancreatitis, which is apparently caused by a massive depletion 
of pancreatic polyamines spermidine and spermine due to in-
ducible activation of their catabolism (Alhonen, L., Parkkinen, 
J.J., Keinänen, T., Sinervirta. R., Herzig, K.H., and Jänne, J. 
(2000) Proc. Natl. Acad. Sci. U.S.A. 97, 8290-8295). When 
subjected to partial hepatectomy, these animals show a striking 
activation of polyamine catabolism at 24 h postoperatively 
with a profound decrease in hepatic spermidine and spermine 
pools and failure to initiate liver regeneration.  
*Here we show that pancreatitis in this model could be to-
tally prevented, as judged by histopathology and plasma a-
amylase activity, by administration of 1-methylspermidine, a 
metabolically stable analogue of spermidine. Similarly, the 
analogue, given prior to partial hepatectomy, restored early 
liver regeneration, as indicated by a dramatic increase in the 
number of proliferating cell nuclear antigen-positive hepato-
cytes from about 1 % to more than 40 % in response to the 
drug. *The present results suggest that the extremely high 
concentration of spermidine in the pancreas, in fact the highest 
in the mammalian body, may have a critical role in maintain-
ing organ integrity. The failure to initiate liver regeneration in 
the absence of sufficient hepatic polyamine pools similarly in-
dicates that polyamines are required for proper commence-
ment of the regenerative process. 
 
4.4. Introduction (Background) 
 The Introduction is not only a presentation of the background of the study but it 
also aims to show the gaps in existing knowledge that the present work intends to fill. 
Introduction is also the place where the motive for the work is presented. The Intro-
duction is not an encyclopedic coverage of the entire literature, but it cites relevant 
original and review articles. The verbs are in the present tense when published works 
are cited. This is actually part of the ethics of science as published studies are consid-
ered as scientific facts. Example: “Inhibitors of polyamine biosynthesis offer a mean-
ingful target for cancer chemotherapy [6].” Except: “Marton et al. [7] showed that 
polyamines are important organic cations.” However, these rules should not be fol-
lowed slavishly, but common sense must be used. Referring to one´s own published 
works the present tense is principally used, yet sometimes it is more natural to use the 
past tense, especially if the sentence begins like: “We recently generated transgenic 
rats that were….” See also the example abstract where the verbs in the introductory 
sentences might have been in the past tense as well. 
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 The Introduction is usually shorter than the Results and Discussion sections (oc-
casionally only 2 to 3 paragraphs). 
 The verbs (bolded) in the example introduction below are all in the present tense, 
as published studies are cited. 
 
   The polyamines spermidine and spermine and their precursor putre-
scine are intimately associated with growth and differentiation of 
mammalian cells, yet their exact cellular functions have not been solved 
(1). In attempts to elucidate the physiological roles of the polyamines, 
we have generated a number of transgenic mouse and rat lines with ge-
netically altered polyamine metabolism. The activation of polyamine 
biosynthesis through an overexpression of ornithine decarboxylase 
brings about many interesting phenotypic changes, such as male infer-
tility (2,3), yet these studies are complicated by the fact that overex-
pression of ornithine decarboxylase only expands tissue putrescine 
pools as the diamine is not further converted to spermidine and sper-
mine (4,5). Much more severe distortion of tissue polyamine pools has 
been achieved by activation of polyamine catabolism through an over-
expression of spermidine/spermine N1-acetyltransferase (SSAT)1 in 
transgenic rodents. The latter enzyme catalyzes the rate-controlling re-
action in the catabolism of spermidine and spermine. After being acety-
lated, spermidine is converted to putrescine and spermine to spermidine 
by the action of polyamine oxidase (6). Overexpression of SSAT in 
transgenic rodents results in profound changes in tissue polyamine 
pools, such as the massive accumulation of putrescine, appearance of 
N1-acetylspermidine, and decrease in spermidine and/or spermine pools 
(7). The alterations in polyamine homeostasis are accompanied by bi-
zarre phenotypic changes, such as the early and permanent loss of hair, 
extensive wrinkling of the skin upon aging, lack of subcutaneous fat 
(7), and reduced life span (5). We recently generated transgenic rats in 
which SSAT expression is driven by heavy metal-inducible mouse met-
allothionein I promoter (8). 
 
 The first abbreviation (SSAT) of the paper appears in the introduction (there were 
no abbreviations in the summary, which is advisable). The superscript refers to the list 
of abbreviations in the footnote of the first page. The term rate-controlling (under-
lined) is infrequently used in comparison with the extremely widely used term rate-
limiting. Both refer to a reaction of a metabolic pathway, the rate of which is the 
slowest among the enzymes of the pathway. Rate-controlling is the preferable term as 
a metabolic pathway may function entirely normally even at half maximum rate of the 
controlling enzyme where the latter reaction is not any more limiting. 
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 The example introduction continues. In articles of most biomedical journals, the 
last paragraph of the Introduction serves as an additional summary, which is, how-
ever, written in a different way and may have a distinct approach in comparison with 
the ordinary summary. The verbs are again in the  past  tense when one´s own results  
 
The metallothionein promoter directs the expression of SSAT mainly 
into liver and pancreas in a heavy metal-inducible fashion. Exposure of 
the transgenic rats to nontoxic does of zinc, results in an immense in-
duction of SSAT activity in the pancreas, a profound depletion of pan-
creatic spermidine, and spermine pools and acute pancreatitis (8). The 
fact that pancreatitis can not be prevented by inhibition of polyamine 
oxidase, which generates hydrogen peroxide and a reactive aldehyde, 
led us to conclude that the organ inflammation is causally related to the 
profound depletion of spermidine and spermine (8). We subsequently 
subjected these transgenic rats to partial hepatectomy and found a strik-
ing stimulation of SSAT activity that was associated with a rapid deple-
tion of hepatic spermidine pool at 24 h after the operation (9). Under 
these conditions, the transgenic rats failed to initiate liver regeneration, 
as judged by lack of proliferative activity and organ weight gain. The 
regeneration was restored only after spermidine concentration returned 
to the preoperative level, presumably due to enhanced ornithine decar-
boxylase activity (9). 
*Using the transgenic rats with activated polyamine catabolism, we 
show here that zinc-induced pancreatitis could be prevented by a prior 
administration of 1-methylspermidine, a metabolically stable analogue 
of spermidine that is supposed to fulfill most of the putative cellular 
functions of spermidine. In a similar fashion, the analogue alleviated 
the proliferative block in the transgenic rats, which was in all likelihood 
caused by spermidine depletion during early liver regeneration.   
* These experiments appear to indicate that spermidine is specifically 
involved in the maintenance of pancreatic integrity and in the initiation 
of rat liver regeneration.  
 
are described except in the last sentence, which represents conclusions. In a randomly 
selected sample of articles in biomedical journals, about 75 % of papers adhered to 
this style while in the rest of papers the last paragraph was something like the follow-
ing: ”We have studied here the relationship between X and Y.” In terms of the whole 
article, the conclusion may appear in three different places: In the Summary, in the 
last paragraph of the Introduction and in the Discussion sections. 
 Most of the verbs in latter part of the Introduction are in the present tense when 
one´s own published studies are cited, yet in many instances it is a matter of taste 
whether to use present or past tense. 
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 The very last paragraph (E) of the Introduction now represents the summary, the 
wording of which differs from that in the ordinary Summary and the last sentence 
(E) contains conclusions with verbs in the present tense. 
 
4.5. Materials and Methods (Experimental Procedures) 
 This section should give sufficiently detailed information of the methods that al-
lows a competent scientist to repeat the experiments. If the method used has been 
published in a standard journal, no description is needed and a journal citation is suf-
ficient. However, if the method has been published in an exotic forum (e.g. “Savolax 
Journal of Gastrointestinal Diseases of the Mosquito”), which is not easily available, 
the description of the method is surely in order. Sometimes when citing published 
methods, the citations are linked in such a way that the author cites his/her own modi-
fication of the method without giving the description of the original method. This may 
create problems to find out the original method. 
 Subheadings are commonly used in Material and Methods section. The first sub-
heading covers usually biological materials (patients, animals, cells etc) and the sub-
sequent subheadings cover materials (including chemical syntheses) and analytical 
methods. The last subheading covers statistical methods. Conventional statistical 
analyses (t test, analysis of variance, etc.) are neither described nor cited. In the case 
when commercial software has been used, the name of the package and its supplier 
are given. Be careful with the syntax of the description of the methods. The following 
is an example of a very agonizing method. “After standing in boiling water for an 
hour, we examined the flasks.” The following example represents a “soluble” method. 
“The radioactivity was determined by the trichloroacetic acid-soluble method of Brit-
ten et al.” In this section all the verbs are in the past tense, except: “The data are ex-
pressed as…”. 
 The Materials and Methods section is usually the easiest part to write and there-
fore is tempting as a starting point for the writing. Although this is not forbidden, it is 
highly advisable to start the writing from the Summary. 
 Even though an article dealing with basic research and a clinical paper are struc-
turally identical, the two types of papers differ from each other particularly with re-
gards to the Materials and Methods section. In a clinical study, this section is usually 
divided into three parts. The first part is Study design describing the method of ran-
 18 
domization, type of blinding (single-blind, double-blind, open etc), type of control 
(placebo, active medication), parallel groups or cross-over and single-center or multi-
center. The second part is Study population, i.e. healthy subjects or patients with par-
ticular disease, inclusion and exclusion criteria, health conditions, age, gender, ethnic 
background, height and weight, ethics-related issues, such as written informed con-
sent, protocol reviewed and approved by Institutional Review Board. The third part 
describes the Treatments: drugs and dosages, route of administration, composition of 
placebo (if placebo-controlled). For drugs, generic names are used (after first mention, 
give the trade names, manufacturer and the location of the manufacturer). These three 
parts can also be combined under a single subheading of “Subjects and study design”. 
 Below is an authentic example of “Experimental Procedures”. 
EXPERIMENTAL PROCEDURES 
 
  Generation of Transgenic Rats- The production of transgenic Wistar rats 
harboring the metallothionein-SSAT fusion gene (10) has been described ear-
lier (8, 11). Partial hepatectomy was carried out according to the original 
method of Higgins and Anderson (12). The Institutional Animal Care and Use 
Committee of the University of Kuopio and the Provincial Government ap-
proved the animal experiments. 
  Chemicals- 1-Methylspermidine was synthesized from 3-aminobutanol as 
described earlier (13) and administered in saline. Zinc was administered as 
zinc sulfate dissolved in distilled water. 
  Analytical Methods- Polyamines and their derivatives were determined with 
the aid of high-performance liquid chromatography as described by Hyvönen 
et al. (14). SSAT activity was assayed according to Bernacki et al. (15). a-
Amylase activity was determined from heparinized plasma using an analyzer 
system Microlab 200 from Merck. 
  Histological Analyses of the Pancreatic Specimens- Formalin-fixed pancre-
atic specimens were embedded in paraffin, cut into 5-mm-thick slices, and 
stained with hematoxylin/eosin. The stained section were coded and blindly 
scored by the participating gastroenterologist (Karl-Heinz Herzig) according 
to the method of Niederau et al. (16). The details of the histological scorings 
are presented in Table I. 
  Immunohistochemistry of Proliferating Cell Nuclear Antigen (PCNA)- 
PCNA was detected from formalin-fixed paraffin-embedded tissue sections as 
described in detail earlier (9). 
  Statistical Analysis- The data are expressed as means ± S.D. One-way analy-
sis of variance with Dunnett´s post hoc test for multiple comparisons was used 
for the statistical analyses with the aid of a software package, GraphPad Prism 
3.0 (GraphPad Software, Inc., San Diego, CA). 
 
 
 Note that the section contains several subheadings. With two exceptions, all the 
verbs are in the past tense. For understandable reasons, the verbs are in the present 
tense in expressions: “Scorings are presented in Table 1” and “The data are ex-
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pressed as.” As the paper includes animal experiments, these must have been ap-
proved by the “Institutional Animal Care and Use Committee (IACUC).” As shown, 
there is no citation to and no description of the statistical method (one-way analysis of 
variance), but the commercial software package and its supplier are given. 
 
4.6. Results 
 In terms of readability, the text should be intelligible without the illustrative mate-
rial (figures and tables) and the illustrative material understandable without the text. 
The verbs are always in the past tense when one´s own new results are described, ex-
cept “Table 1 shows” and “Fig. 1 depicts”). If the data are presented in a figure, they 
are not duplicated in a table or vice versa. The legends to the figures are on separate 
sheets with numbering. The figures likewise are on separate sheets. This means that 
the figures are not embedded in the text, although the journal may require to mark 
their approximate positions in the manuscript. The tables are also on separate sheets 
with their titles and captions (mostly as footnotes to the tables). Some journals (short 
articles) combine the Results and Discussion sections (Results and Discussion), but 
this is less readable than separate sections. Most journals do not encourage the inclu-
sion of discussion in the Results section. 
 A central question in the presentation of results is whether to use a table or a fig-
ure. There is no unambiguous rule, but generally a table can be used always whereas a 
figure may become unreadable if containing too many variables. If one likes to give 
exact numerical values then a table is better, but if one likes to show trends of the 
data, then a figure is more illustrative. If the numbers just sit there then a table is ap-
propriate. Decide also how many significant digits (3 to 4) are used in the tables and 
be consistent. 
 Many authors tend to use tables and figures even in cases where the experimental  
 
Table 1. Sensitivity of wild-type and 
transgenic mice to hepatotoxins
Wild type Transgenic
5/35 (14)a 9/34 (26)
aNumber of deaths/total (% within
 parenthesis). p = 0.24.
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results could be more appropriately presented in the text, especially when there are 
only a few variables. The example above represents an entirely unnecessary table. 
There is no need to tabulate the results, especially as the difference is not statistically 
significant (p = 0.24). If the findings should have to be included, the following sen-
tence in the text would do it. “The difference between the mortality rates - 15 % 
(5/35) for wild-type and 26 % (9/34) for transgenic mice - was not statistically signifi-
cant.” 
 Similarly, the figure shown below is unnecessary. It can be stated in the text with 
a following phrase: “Among 48 mice, which were transferred out of barrier for an av-
erage of seven days, four aquired infection.” 
 
 
Caution should be exercised when numbering the Y-axis. The following example 
represents an experiment where cell growth has been recorded as the function of time. 
 
The number of the cells at each time-point is reported as millions and hence the cor-
rect exponent will be 10-6 (the numbers are divided by one million) and not 106 (the 
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numbers are multiplied by one million). The confusion in this respect may have been 
derived from tachometers of the cars where the revolutions/min appear as 1-2 digits 
and it is indicated that they have been multiplied by one thousand (rpm x 1000). 
 Some journals limit the total number of figures and tables. The number of the fig-
ures can be reduced by combining several figures as different panels in the same fig-
ure. The above figure represents one figure with two panels (A and B). 
 Microscopic pictures should be provided with scale bars, with the aid of which 
the magnification can always be easily computed (the size of the picture can change 
during the processing of the manuscript). 
 Before starting to write the Results section, the order of the presentation of tables 
and figures can be outlined on separate sheets of paper. According to the sketch be-
low, the first results (“SSAT activities”) will only be presented in the text (not as a ta-
ble or figure) followed by figures and tables in their running order. The results of the 
repeated experiment are incorporated into the text with exact numerical values and 
statistical significances. 
 
 The following authentic parts of the Results section are organized according to 
the outline above. The section begins with results that have not been tabulated but are 
incorporated into the body of the text (E). Note that all the verbs are in the past tense 
when one´s own results are described, except: “Fig. 1d depicts the accumulation…” 
 In the later part of the Results section, the verbs likewise are consistently in the 
past tense, when the present results are described. Exceptions are the sentences de-
scribing PCNA (proliferating cell nuclear antigen) where the verbs are in the present 
tense: “PCNA is a convenient and commonly used method to grade proliferative activ-
ity in various tissues. PCNA expression is closely correlated with the S-phase of the 
Results
-SSAT activities in text
-Fig. 1. Pancreas
-Fig. 2. Amylase
-Fig. 3. Histology
-Table I Scoring
-SSAT activities in text
-Fig. 4. Liver
-Fig. 5. PCNA
-Repeated experiment in
 text
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cell cycle (17).” The obvious reason for the use of the present tense is the citation to 
existing literature. In addition: “Fig. 5 shows…” and “Fig 5b depicts…” 
 The Results section ends up with the description of the results of the repeated ex-
periment. Principally, every experiment should be repeated in science. In the vast ma-
jority of instances, the results of a repeated experiment are settled in the text with the 
following sentence: “The experiment was repeated essentially with identical results.” 
RESULTS 
 
Depletion of Pancreatic Polyamines by Zinc- * Administration of zinc 
(10 mg/kg) alone or with methylspermidine (50 mg/kg) did not influ-
ence SSAT activity in syngenic rats, whereas in transgenic rats, the en-
zyme activity rose from 36 ± 7.1 to 4270 ± 560 pmol/mg/10 min in re-
sponse to zinc. Inclusion of the analogue with zinc only slightly in-
creased SSAT activity over that achieved with zinc alone. u The 
changes in pancreatic polyamine pools in response to zinc and methyl-
spermidine are depicted in Fig. 1. Putrescine pools (Fig. 1a) remained 
very low regardless of the treatment in nontransgenic animals, whereas 
transgenic animals typically showed very high putrescine pools already 
without any treatments, indicative of constitutive activation of poly-
amine catabolism. The various treatments only marginally altered pan-
creatic putrescine pools (Fig. 1a). The pancreatic spermidine pool re-
mained virtually unaltered after zinc alone or with the combination of 
the analogue in the syngenic animals (Fig. 1b) but was dramatically (by 
90%) reduced in transgenic animals in response to zinc. Administration 
of methylspermidine had little effect on zinc-induced depletion of 
spermidine (Fig. 1b). Although zinc alone or in combination appeared 
to decrease the pancreatic spermine pool in syngenic animals, its effect 
in transgenic animals was much more striking as the spermine pool was 
decreased by more than 80% (Fig. 1c). Fig. 1d depicts the accumulation 
of the analogue in the pancreas after a single dose or two doses. As in-
dicated in the figure, the analogue effectively accumulated in the pan-
creas, apparently with no further metabolism. 
 
 On the other hand, if the experiment has been properly repeated and analyzed, the  
actual results can be presented in the paper as well. Due to possible space limitations, 
the results can be incorporated into the text instead of using tables or figures. As 
shown in the later example of the Results section, the numerical results of the experi-
ment have been given with scatters, statistical analyses have been carried out, and the 
significances between the differences of the means have been indicated. 
 The very last sentence (ø) of the Results section distinctly represents a conclu-
sion and hence the first verb is in the present tense: “It thus appears that…” The ex-
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amples of the Results section are incomplete, as the pages containing illustrative ma-
terial have been intentionally omitted. 
Effect of Partial Hepatectomy and Methylspermidine on liver Weight 
Gain and Proliferative Activity- Fig. 5 shows liver weight gain (Fig. 5a) 
and the PCNA labeling index (Fig. 5b) at 24 h after partial hepatectomy 
without or with a prior injection of methylspermidine in syngenic and 
transgenic animals. The weight gain of the liver remnant was signifi-
cantly increased in syngenic animals, but not in transgenic animals, at 
24 h after the operation (Fig. 5a). Methylspermidine had no effect on 
the weight gain in non-transgenic animals but significantly increased 
the organ weight in transgenic animals (Fig. 5a). PCNA was used as an 
indicator of proliferative activity during liver regeneration. Immunohis-
tochemical detection of PCNA is a convenient and commonly used 
method to grade proliferative activity in various tissues. PCNA expres-
sion is closely correlated with the S-phase of the cell cycle (17). Fig. 5b 
depicts the PCNA labeling index before partial hepatectomy and at 24 
h postoperatively in syngenic and transgenic animals without or with 
methylspermidine treatment. In resting liver, only about 1% of the he-
patocytes were PCNA-positive. In syngenic animals, the number of 
PCNA-positive cells increased sharply to over 30% at 24 h after the 
operation, whereas in transgenic animals, the number of positive cells 
remained at the low preoperative level at this time point (Fig. 5b). Ad-
ministration of the analogue did not change the PCNA labeling index in 
syngenic livers but dramatically increased the number PCNA-positive 
cells in transgenic livers from about 1% to more than 40% (Fig. 
5b).*We repeated the experiment with other groups of syngenic and 
transgenic rats. In this experiment, PCNA-positive hepatocytes ac-
counted for 0.5 ± 0.1% in resting syngenic liver. The number of posi-
tive cells rose to 10.7 ± 3.5% at 24 h postoperatively without the ana-
logue (p < 0.001) and to 9.8 ± 1.5% with the analogue (p < 0.001). The 
corresponding figures for the transgenic animals were 0.20 ± 0.0 before 
the operation, 0.42 ± 0.24% at 24 h postoperatively without methyl-
spermidine, and 25.9 ± 4.9% with methylspermidine (p < 0.001).uIt 
thus appears that the analogue completely reversed the proliferative 
block in transgenic livers. 
 
 
4.7. Discussion (and conclusions) 
 The main purpose of this section is to relate the new results obtained to the exist-
ing knowledge. In many instances, the Discussion section is the most difficult part to 
write. Discussion is not the place to summarize all the results obtained and to list 
other’s work, especially if they have been described in the Introduction section. If the 
Introduction contains a formulated question, Discussion is now the place to tell how 
well the new results answer this question. When published works, including one´s 
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own, are discussed, the present tense is used whereas description of new results ob-
tained the past tense is used. The following example shows that both tenses can ap-
pear in the same sentence: “Spermidine serves as a precursor of hypusine [8], but our 
own present results did not indicate that growth inhibition was mediated through hy-
pusine depletion (Table 1).” The first part of the sentence refers to a published fact 
while the latter part refers to one´s own new results presented in the table of the paper. 
 Subheadings are uncommon in the Discussion section, yet they may occur. 
 Below is an example of the beginning of an authentic Discussion. 
 
DISCUSSION 
The present results strongly support the notion that spermidine, and 
possibly also spermine, plays a critical role in the maintenance of pan-
creatic integrity. In the present transgenic model of pancreatitis, pro-
found spermidine and spermine depletion was achieved by the induc-
ible activation of their catabolism. Under the condition of intense acti-
vation of polyamine catabolism, depleted pancreatic polyamine pools 
could be replenished by natural polyamines as they would be rapidly 
degraded without any net tissue accumulation.2 We therefore tested 1-
methylspermidine as a substitute for spermidine. Methylspermidine is 
reported to be metabolically stable as it is not a substrate for SSAT and 
serves only as a poor substrate for spermine synthase (18). Moreover, it 
appears to fulfill many of the putative functions of spermidine, such as 
promoting the conversion of right-handed B-DNA to left-handed Z-
DNA (18, 19), serving as the substrate for deoxyhypusine (integral part 
of eukaryotic initiation factor 5A) and reversing cytostasis caused by 
inhibitors of polyamine biosynthesis (18, 20). We also found that this 
analogue was not an inhibitor of SSAT but induced the enzyme in 
transgenic animals.3 The fact that methylspermidine prevented zinc-
induced pancreatitis in transgenic rats proves that the profound deple-
tion of the pancreatic polyamines was causally related to the develop-
ment of the organ inflammation and not, for instance, oxidative stress 
created by polyamine oxidase with its reaction products hydrogen per-
oxide and aminoaldehyde. The process in which the polyamines  are 
required to maintain pancreatic integrity is not known. It is tempting to 
speculate that spermidine acts through its specific function to serve as 
precursor for hypusine and the initiation factor 5A (21), especially as 
intense protein synthesis is continuously going on in the pancreas. 
However, reduction of hypusine content in the absence of sufficient 
spermidine pool appears to be a slow process in which a 50% decrease 
in hypusine level takes nearly a week (22), yet the pancreatitis in the 
present model developed just in 24 h. 
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  It should be noted that the tense of the verbs strictly complies with the sources of 
the references, i.e. published works or one´s own new results. There are also refer-
ences to one´s own unpublished results in the text (footnotes 2 and 3), in which the 
tense of the verbs is the past one. Unpublished results never appear in the list of refer-
ences but are listed in the footnotes like here or appear within parentheses in the text 
(“Our unpublished results”). Some journals (like the example journal) require that 
unpublished results have their own lists of authors (see the two footnotes at the last 
page of discussion). In some instances, references to unpublished results can be in the 
form of personal communications (e.g. “A. Khomutov, personal communication”). 
However, there is a possibility that the journal requires a written approval from the 
person in question. The Discussion begins with a conclusion, for which support is 
searched for from published works and from own results. The Discussion continues 
by offering or excluding mechanistic possibilities, with the aid of which the results are 
related to the existing knowledge. The last sentence of the above example tends to 
exclude a certain mechanism by referring to existing literature and to the new results. 
Note that this sentence contains both present and past tenses of verbs depending on 
the source of the reference (published work or own results). Discussion continues:  
 
   As in the case of pancreatitis, methylspermidine appears to cover the 
requirement for spermidine also in rat liver regeneration. The striking 
induction of the SSAT transgene and profound depletion of hepatic 
spermidine pool at 24 h after partial hepatectomy led to a dramatic 
block of proliferation, which was, however, equally dramatically re-
versed by the administration of methylspermidine. Many of the ex-
perimental findings, such as the early expansion of spermidine pool in 
regenerating normal liver and the extremely close correlation between 
spermidine concentration and hepatic proliferative activity (9), seem to 
indicate that spermidine is specifically required for the initiation of rat 
liver regeneration. This view is likewise supported by our earlier find-
ings indicating that the maintenance of normal or near normal hepatic 
spermidine pool in the transgenic animals apparently occurs at the cost 
of spermine, the pool of which is reduced by 90% (9). In any event, to 
our understanding, the present experiments represent for the first time 
a situation in which polyamine depletion has been successfully cor-
rected in vivo. 
   It is highly likely that the use of polyamine analogues or compounds 
alike is not limited to the prevention of pancreatitis in this specific 
transgenic model as our preliminary experiments have indicated that an 
activation of polyamine catabolism is also involved in other experimen-
tal models of pancreatitis. Similarly, the present approach may have use 
in hepatoprotection in case of liver damage. 
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 The above continuation of the discussion now begins to deal with the second part 
of the title, namely liver regeneration. General conclusions of mechanisms of acute 
pancreatitis and the possible relationship of the new results to the development of the 
disease appear at the very end of the Discussion section. The last paragraph of the 
Discussion contains forward-looking statements about new approaches of drug devel-
opment. Note that almost all verbs are in the present tense in this part of the Discus-
sion. The references to unpublished results with appropriate lists of authors appear in 
the footnote. 
The acknowledgments follow right after the Discussion. According to the style of 
Journal of Biological Chemistry only technical help (and people in general) is thanked 
here while the grants are listed in the footnote of the title page. 
  
   Acknowledgments- We thank Tuula Reponen, Aune Heikkinen, and Sisko 
Juutinen for skillful technical assistance. 
_______________________________________________________________ 
   2T.-L. Räsänen, L. Alhonen, R. Sinervirta, T. Keinänen, and J. Jänne, unpub-
lished results. 
   3T.-L. Räsänen, L. Alhonen, R. Sinervirta, T. Keinänen, K.-H. Herzig, S. 
Suppola, A. R. Khomutov, J. Vepsäläinen, and J. Jänne, unpublished results 
 
 
 Below is an example of a more common Acknowledgments also listing the grant 
sources. 
  
4.8 References 
 It is imperative that the references strictly comply with the style of the journal, to 
which the manuscript is aimed. Get familiar with the instructions to the authors, have 
a recent issue of the journal and check the list of references. As regards the abbrevia-
tions of the journals, a general rule is that single-word names (“Science”) are not ab-
breviated irrespective of the length of the word (“Biomedicine, Gastroenterology”). 
Only published or accepted (“in press”) papers are listed as references. As indicated 
Acknowledgments
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Heikkinen and Sisko Juutinen for their
skillful technical assistance and Dr. Carl W.
Porter for the synthesis of DENSPM. This
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earlier, references to unpublished results and submitted manuscripts appear either in 
the text (within parentheses) or in footnotes. Depending on the journal, references 
published as a congress abstracts appear in footnotes, in the text or they may be in-
cluded as ordinary references. Some journals limit the number of references (e.g. 40). 
Be careful when preparing the references, as mistakes simply are signs of careless-
ness. In general, do not cite articles that you have not read. According to a recent 
analysis, erroneous references frequently are identical indicating that the reference has 
been copied from somebody’s article without reading the original paper. The men-
tioned analysis came to the conclusion that only 50 % of the cited articles have been 
read. 
 Below is an authentic example of erroneous references. 
 
Original article                              Citations 
 
JÄNNE, J.  J. Biol. Chem. 246 1725 (1971)                464       
JÄNNE, J.  J. Biol. Chem. 246 1726 (1971)                  17 
 
Book chapter 
 
JÄNNE, J. Adv. Enzyme Regul. 24 125 (1985)                  16 
JÄNNE, J. Adv. Enzyme Regul. 24 125 (1986)               28 
 
 
 The examples are an original article, which is readily available, and a book chap-
ter, which is not that easily available. Note that in both cases the faulty references are 
identical. Erroneous citations (underlined) to the original article comprise only about 
4 % of all citations while those to the book chapter greatly outnumber the correct cita-
tions. The fact that the faulty references are identical obviously indicate that they are 
derived from the same erroneous source. In other words, the authors of the erroneous 
citations have apparently not read the primary paper, but the citation has been picked 
up from the list of references of someone else. 
 
5. Writing a review article or book chapter 
 
 A review article or a book chapter fundamentally differs from a primary paper 
and does not comply with the IMRAD format. A review article lacks the Materials 
and Methods as well as the Results sections. The Introduction and Discussion sections 
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are greatly expanded. At its best, the review article is not an encyclopedic coverage of 
all possible literature but it critically reviews the existing knowledge and offers new 
approaches and syntheses of earlier work. A review article is aimed at a much wider 
readership than a primary publication and hence compromises have to be made with 
regards to the presentation of detailed information. In practice, the writing of a review 
article is started by preparing the table of contents and an outline of the article, fol-
lowed by collecting and reading the primary papers. In most cases, the review article 
is solicited by a journal but can also be offered to a journal. Many of the journals have 
“Reviews Editor”, who is the person to be approached with the writing proposal, pos-
sibly by sending a summary of the planned article. The review articles are usually 
much more cited than the primary papers. 
 
6. Doctoral thesis 
 
 In principle, a doctoral thesis is a scientific publication, which, however, can 
cover (and usually covers) more than one topic and more than one approach to the 
topic. The monograph-type thesis fully complies with the IMRAD format, yet the In-
troduction (or Review of the literature) is usually substantially longer than in a pri-
mary publication. A thesis based on published papers has features of a primary paper 
and a review article and in principle complies with the IMRAD format. This thesis 
format likewise has a relatively long Introduction section while the Materials and 
Methods as well as the Results sections are shorter due to frequent citations to the 
original publications. One should be careful with the Abstract as it usually ends up to 
international distribution (“Dissertation Abstracts”). It is an established practice that a 
thesis contains (usually after the Introduction) a special section called “The aims of 
this study”, which in the vast majority of cases has been prepared afterwards. This 
section, however, is unnecessary as an outline of the aims can be incorporated into the 
last paragraph of the Introduction (or Review of literature). This section does not be-
long either in a primary publication or review article but rather in a grant proposal. 
 In a doctoral thesis based on published articles, there are certain issues, on which 
the reviewers and public examiner of the thesis will pay special attention. (i) Do the 
original publications form a logical entity suitable for a doctoral thesis? (ii) The con-
tribution of the author to the original publications (authorships in the original papers). 
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(iii) The quality of the original publications and the publication forums. (iv) Possible 
development of entirely new methods and how demanding the methods used are 
(“state-of-the-art methods”). (v) What is the contribution of the obtained results to the 
particular field of research and possible scientific breakthroughs. (vi) Acquaintance 
with the literature. (vii) Maturity and relevance of the discussion. (vii) Linguistic 
quality. Finally, the public examiner assesses, how well the doctoral candidate de-
fended his/her thesis at the public examination. 
 
7. Poster 
 
 A poster is a kind of graphic presentation, in which the author has his/her research 
project on display. Although extremely common today, the poster tradition is not very 
old.  The poster presentations at national and international scientific meetings became 
more widely used only in the 1970´s. The poster likewise complies with the IMRAD 
format, yet graphic considerations and aim to simplicity centrally influence the orga-
nization and content of the poster. The Introduction is very short (1 to 2 sentences) 
clearly stating the aim of the work. Similarly, the experimental section is very short 
not necessarily describing the individual methods but merely the methodological ap-
proaches. Unlike in primary publication, the Results section is the main part of the 
poster. Short discussion is often replaced by Conclusions in the form of short num-
bered sentences. The number of references is kept at a minimum. The majority of bad 
posters are bad because the author tries to present too many matters. If the author of a 
poster has to explain the content of the poster rather than answering scientific ques-
tions, the poster has certainly failed. 
 
8. Verbal presentation 
 The audience listening to a verbal presentation is more heterogeneous than the 
readers of a primary publication and the message of a verbal presentation has to be 
digested in a very short time. Therefore, a verbal presentation should be pitched at 
more general level than a written publication. The oral presentation starts with the 
identification of the problem and finishes by offering the solution. The organization 
and the use of the illustrative material are of central importance for a successful verbal 
presentation. If the message of a picture does not come across in about five seconds, 
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the picture is poor. The use of excessive tricks offered by computer programs for slide 
shows may even cloud the whole message of the picture. The number of slides has to 
be fit according to the scheduled time, e.g. one slide per every two minutes of the 
presentation. The fundamental difference between verbal and written presentations is 
the fact that a written paper contains all methodological details (making it possible to 
repeat the experiments) but an oral presentation certainly does not. Those who are not 
native in English can rehearse the pronunciation of American English at Merriam-
Webster on-line dictionary (http//www.m-w.com/dictionary.htm). 
 
9. Submission of the manuscript and editorial correspondence 
9.1. Publication forum 
After the completion of the manuscript, one has to decide which journal the 
manuscript will be submitted (in fact, this decision has been reached already before 
starting the writing process in accordance with the Instructions to the Authors). The 
general aim is to publish the manuscript in a journal as prestigious as possible. On the 
other hand, a distinct advantage of a less prestigious but more specialized journal is 
the fact that the latter usually reaches a more expert readership than the former. A 
clear disadvantage of multidisciplinary journals of high prestige (Science, Nature, 
PNAS) is the strict space limitations not possibly allowing the presentation of all the 
results of the study. A prestige factor (“impact factor”), which is based on the number 
of citations directed to the journal articles, has been computed for nearly all journals. 
The impact factor is derived by dividing the number of citations to the articles of the 
journal over a period of two years by the total number of articles published during the 
same time period. The impact factor for journals publishing primary papers may vary 
between near zero to more than 30. The use of the impact factor as a quality measure 
for an individual publication has been heavily criticized as, for instance, only one 
sixth of the total articles of the journal determines its impact factor. The best quality 
criterion for an individual scientific paper obviously is the number of citations spe-
cifically directed to that publication.  In any event, the impact factor is going to re-
main and it will distinctly influence the choosing of the publication forum. Finland is 
apparently the only country in the world where the impact factor is included in the 
legislation, as the publication forum has certain influence on the distribution of Gov-
ernment special funds to university hospitals. 
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Below is the latest list (2004) of impact factors for selected scientific journals 
publishing mainly primary papers. 
 
Impact factors of selected journals ( 2004) 
 
New Engl. J. Med. 38.570   PNAS    10.452 
Nature 32.182   Blood        9.782  
Science 31.853   Diabetes         8.848             
Cell 28.389   Mol. Cell. Biol.    7.822  
Nat. Genet. 24.695   Cancer Res.      7.690  
Nat. Biotechnol. 22.355   Nucleic Acids Res.   7.260           
Genes & Develop. 16.385   FASEB J.          6.820  
J. Exp. Med. 14.588   J. Biol. Chem.           6.355 
Neuron 14.439   Mol. Endocrin.     5.872 
J. Clin. Invest. 14.204   Gene Ther.      4.977      
Gastroenterology 13.092   Int. J. Cancer      4.416  
Circulation 12.563   Biochem. J.      4.278     
EMBO J. 10.492   Biochemistry      4.008     
 
A complete list of all journals can be obtained at: http//isi2.isiknowledge. com/ 
portal.cgi. 
 
9.2. The Editorial Offices of scientific journals 
 The Editorial Offices of scientific journals mostly consist of elected and paid offi-
cials. To the former personnel belong usually the Editor-in-Chief, Editors, associate 
Editors and the members of Editorial Board. The paid personnel commonly include 
technical Editors, such as Managing Editor, Desk Editor and Copy Editor. However, 
with regards to the acceptance of a manuscript for publication, the peer review proc-
ess and the reviewers occupy a central position. The reviewers may be members of 
the Editorial Board, members of a larger Editorial Advisory Board or independent 
scientists (ad hoc referees). The latter reviewers are anonymous experts in a particular 
field of research. The reviewers do not make decisions with regards to the acceptance 
of the manuscript for publication but their recommendations and suggestions for 
amendments have an essential impact on the acceptance process. The actual decisions 
will be made by the Editors of the journal. If the reviewers agree, the decision is easy 
but, if their opinions are conflicting, the Editor has to decide or ask for a further opin-
ion. 
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 As indicated, the peer review process is intimately involved in the processing of 
the manuscript for publication. In fact, “peer review” is defined by Merriam-Webster 
on-line dictionary as “A process by which something proposed (as for research or 
publication) is evaluated by a group of experts in the appropriate field.”  
 Fig. 3 depicts the manuscript in the editorial process. 
       Fig. 3. The manuscript and the editorial 
                   process.*elected, **paid officials  
 
9.3. Covering letter (cover letter) 
 When the manuscript is submitted it is always is accompanied by a covering let-
ter. The letter format is usually very simple. Some of the journals require a formal 
statement that the manuscript has not been published before and is not under consid-
eration for publication: “This manuscript has not been published before nor it is under 
consideration for publication elsewhere”. A statement about the authorship may also 
be required: “All authors agree upon the content of the manuscript and being listed as 
authors”. The covering letter also contains a statement regarding the results and their 
novelty, i.e. why should these results to be published. 
 Nearly all journals encourage the authors to provide names of suitable referees 
though these wishes of the authors are not necessarily respected. The authors can 
likewise suggest names of scientists not to be consulted as reviewers (e.g. existing 
conflict situation). In principle, such wishes are almost always respected by the jour-
nals. 
 The following is an authentic (the name of the Associate Editor has been omitted) 
example of a covering letter. As indicated, the author suggests that a given person (the 
<Editor-in-Chief (Editor)*
< Editors (Associate Editors)*
< Editorial Board (Editorial
< Advisors, ad hoc referees)*
Manu-
script
Editor/Associate Editor
Decision
Acceptance < Managing Editor**
< Desk Editor**
< Copy Editor**
Referees
Peer
review 
Comments and
suggestions 
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name is imaginary) is not consulted as a reviewer. Note also that the last sentence of 
the letter provides a short justification for the publication. 
Editorial Office 
Journal of Biological Chemistry     April 12, 2002 
 
Dear Sirs: 
 
The enclosed manuscript entitled “Targeted disruption of sper-
midine/spermine N1-acetyltransferase in mouse embryonic stem cells” 
by K. Niiranen, M. Pietilä, T.J. Pirttilä, A. Järvinen, M. Halmekytö, V.-
P. Korhonen, T.A. Keinänen, L. Alhonen and myself is respectfully 
submitted for publication in the Journal of Biological Chemistry.  
 
We would appreciate that Dr. James E. Smith is not consulted as a re-
viewer. 
 
The manuscript provides novel information on the role of SSAT in 
polyamine homeostasis and sensitivity to polyamine analogues. 
 
Yours sincerely, 
 
Juhani Jänne, M.D., Ph.D. 
Professor of Biotechnology 
 
 
 Some journals (e.g. Nature family, Science, FASEB J.) give the opportunity for a 
“preview” of the manuscript. In that case, the summary of the paper and a covering 
letter are sent to the Editorial Office for the preview. In many instances, this is not 
advisable because usually the decision is made by Managing Editor ex officio not nec-
essarily consulting the Editors. It is better to send the complete manuscript to the Edi-
tor who then decides whether peer review is carried out. Some journals (very few) 
like to carry out the peer review “double-blindly”, in which case the names of the 
authors and institutions are not disclosed to the referees. 
 
9.4. Criteria for acceptance 
 In general, the better is the journal, the tougher are the criteria for acceptance. 
Only about 5 %, depending on the journal, of the manuscripts are accepted “as they 
stand”. Accordingly, critique will be an automatic outcome. In many cases, the jour-
ney of the manuscript halts already at the Editorial Office without being sent for re-
view. A manuscript solely describing a phenomenon (“Effect of something on some-
thing”) without any mechanistic implications is very likely to be rejected today.
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 The primary rejection rate (requiring a new submission) is in good journals well 
above 50 % while very prestigious journals reject more than 90 % of the manuscripts. 
Reasons for turning down a manuscript include: “Insufficient contribution to the field” 
or when the manuscript has been sent to a multidisciplinary journal (Science, Nature, 
PNAS): “Suits better for a specialized journal.” A more general reason for rejection is 
the requirement for more experiments. After the rejection of the manuscript, one 
should seriously consider another journal after taking into consideration the editorial 
comments received. In case of conditional acceptance, the first thing to do is to clarify 
whether additional experiments are required or would some formal amendments and 
condensation of the text suffice. The response to the critique can also contain counter 
arguments when the authors disagree with the reviewers. 
 
9.5. Editorial response 
 Below is an authentic editorial response to the manuscript mentioned in the ex-
ample covering letter.  
 
Dr. Juhani Jänne 
A.I. Virtanen Institute for Molecular Sciences 
University of Kuopio 
P.O. Box 1627 
Kuopio, FIN-70211, Finland    May 2, 2002 
 
Dear Dr. Jänne: 
Your manuscript entitled “Targeted disruption of spermidine/spermine 
N1-acetyltransferase in mouse embryonic stem cells” has been reviewed 
by the Editorial Board. The Reviewing Editor who evaluated the manu-
script found that you have created an interesting and novel model sys-
tem for studying polyamine homeostasis. The results clearly challenge 
some of the “conventional wisdom” and their publication should be of 
considerable interest. As you will be note from the accompanying 
comments, the Reviewing Editor suggests a drastic revision of your 
Discussion section with a better focus on your novel findings and the 
way in which they contradict or change previous hypotheses on the sub-
ject. When you return to the Journal with a revised manuscript, please 
provide me a detailed listing of changes made from the original. In ad-
dition, in an attempt to stem the growth of the Journal we are asking all 
authors of potentially acceptable manuscripts to shorten them as much 
as possible but at least 10%. 
 
Yours sincerely, 
 
For the Editorial Board 
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 As indicated in the editorial letter, the manuscript is conditionally accepted and 
there is no need for further experiments. The main criticism is directed to the Discus-
sion part of the manuscript that needs to be focused. At the end of the letter, there is a 
requirement for condensation of the manuscript, which is typically demanded by 
nearly all journals. The Editor likewise requires a detailed list of changes made in the 
new version upon resubmitting the revised manuscript. The latter implies that the 
authors deal in their response with all the points raised by the reviewer (see also the 
accompanying response to the critique). The editorial correspondence contains the 
comments of the reviewer to be communicated to the authors (see below). 
 
Comments for authors: 
 
The present studies deal with a mouse embryonic stem cell line in 
which the SSAT gene was disrupted. Since it is X-linked a single 
knock-out results in a null phenotype for ES cells with the XY karyo-
type. 
The characterization of the various cell lines is thorough and the inter-
pretation of most of experiments is very clear: 
 
1) The knockout was achieved and the mutant ES cells did not have 
any SSAT protein or activity. One could suggest that Figures 1 and 
2, and Figures 3 and 4 may be combined into single figure (A and 
B). 
2) The data showing the differential growth inhibition of wt and mu-
tant cells by DENSPM are also clear. One may consider omitting 
Figure 7 since the results can be stated convincingly in the text. 
3) The authors suggest that the analogue can replace the natural poly-
amines (p. 9). Why is it only toxic to wild-type cells? 
4) Revise the Discussion section drastically and focus the discussion 
on the novel experimental findings. 
5) The paper could also benefit from another check on the use of Eng-
lish. 
 
 
In most journals, the reviewers assess the manuscript with regards  to the priority of 
publication and the quality of the manuscript. These assessments are not usually 
communicated to the authors. On the whole, the evaluation process usually takes 
weeks, sometimes months. If the process is prolonged very much, it is advisable to 
consult the Editor with regards to the status of the manuscript. This usually speeds up 
the review process. 
 36 
 The comments of the anonymous Reviewing Editor (see above) typically begin 
with a general statement containing a short description of the results and how they 
have been interpreted. This is followed by detailed comments and suggestions (mainly 
to condense the manuscript). Finally, a language check is asked for. On the whole, the 
criticism is clearly benign and is mainly directed to formalities. 
 If the response to critique and comments has been appropriate, the manuscript is 
likely to be accepted for publication. However, occasionally the reviewers keep bring-
ing up new comments even after a satisfactory response to the original comments. 
This represents an inappropriate editorial procedure and may require a direct contact 
to the responsible Editor. After the final acceptance of the manuscript, the Manag-
ing/Desk Editor starts to deal with the technical issues, such as the revision of the lan-
guage, and may send a number of technical queries, to which the authors must re-
spond carefully. As a final outcome of the technical editing and all the changes, one 
may end up with the following conclusion: “Somebody has murdered my prose!” 
 
9.6. Response to critique 
 The following example again represents authentic correspondence where the 
authors present their response to the editorial comments. Note that the overall nuance 
of the letter is very polite and thanks are expressed for the constructive criticism pro-
vided in the editorial letter. The comments of the Reviewing Editor are dealt in the 
order of their appearance in the editorial correspondence. The changes made in the 
revised manuscript are described in detail and the places of the changes are indicated. 
Some journals, but not this one, require that the changes made must be marked (un-
derlining, shadowing, etc.) in the manuscript. 
 The response to critique satisfied the Editor, and the manuscript was immediately 
accepted for publication. 
 The editorial process ends with proofs, which the corresponding author most 
likely receives as a PDF attachment sent via E-mail. This is the final opportunity to 
make changes (small) in the text. The queries of the Managing Editor are usually 
shown in the proofs and should be properly dealt with. The proofs are accompanied 
by reprint order form that should be filled in. The form usually also contains page 
charge, if any, and charge for color illustrations. 
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Associate Editor 
Journal of Biological Chemistry     May 7, 2002 
 
Re.: Manuscript M2:03599 (Niiranen et al.) 
 
 
Dear Sir: 
 
Thank you for your editorial letter of May 2, 2002 and the accompany-
ing extremely thorough and sound criticism provided by the Reviewing 
Editor. We now enclose a revised manuscript, in which we have ad-
dressed the concerns of the Reviewer to our best understanding. 
The comments of the Reviewer (in order of their appearance) have been 
dealt as follows: 
 
1. The original Figures 1 and 2 have been combined (new Figure 1A 
and B) as well as Figures 3 and 4 (new Figure 2A and B). 
2. The original Fig. 7 has been omitted and the data presented in the 
text. 
3. The description of Fig. 3 (old Fig. 5) (page 9) is modified to indi-
cate that the analogue “could replace the natural polyamines from 
their intracellular binding sites” that would be the major reason for 
polyamine depletion, not the induction of SSAT. The discussion 
concerning the mechanisms of analogue cytotoxicity has also been 
modified (page 12) to offer a third possibility, in which analogues 
exert their cytotoxicity independently both of SSAT and polyamine 
depletion. 
4. The discussion has been focused and condensed as required. 
5. The linguistic mistakes have been corrected. 
 
Due to changes made, we believe that the manuscript is now condensed 
by more than 10%. While hoping that the manuscript now is acceptable 
for publication, we thank again for the sound and very constructive 
criticism provided in your editorial letter. 
 
 
 
9.7. Electronic submission 
 Nearly all major journals offer the possibility (and most of them encourage or 
even require) to submit the manuscript electronically. Electronic submission may, in 
some cases, dramatically shorten the editorial process. At best, the manuscript may be 
accepted for publication in a few days. This is, however, extremely unlikely as the 
most time consuming part of the process is the peer review that takes its own time. 
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The journals and journal families have their own systems for electronic submission, 
yet these are very similar. All the communication takes place through E-mail. Most of 
the journals prefer to receive the main body of the text and the illustrative material as 
a single PDF file and the covering letter as a separate file (pasted in the submission 
form). The PDF file can also be created as a part of the submission process. Today, 
almost all journals accept graphics and pictures only as TIFF or EPS files and hence 
the graphics programs and the statistical software must have an option to save the ma-
terial as these files. Apparently, the PowerPoint files will become acceptable in the 
near future (some publishing houses accept them already). 
 
9.8 Publication or patent? 
 Publishing of the results prevents the patenting in Europe. Publishing is not lim-
ited to a scientific article but likewise covers any public release, such as oral presenta-
tions, congress abstracts, posters, etc. In the U.S.A. (and Canada), a patent application 
can be filed within 12 months after the public release and in Japan within 6 months. 
Patenting is very expensive and it advisable to leave the compiling of the patent appli-
cation for professional people. 
 
10.  Linguistic pitfalls and useful phrases 
  
 This chapter contains a collection of English words and phrases, which may cre-
ate problems at least to those who are not native in the English language. The chapter 
likewise contains useful phrases picked up from scientific literature that can be used 
to enliven the text and to avoid repetition of phrases. 
 
10.1. Misused words 
 “Which/that”, the difference between the words is that which describes but that 
determines. Examples: “Mice, which are transgenic, also have shorter tails” and 
“Mice that are transgenic also have shorter tails.” Note the difference between the 
sentences. The first sentence means that all mice are transgenic whereas the latter sen-
tence means that only some mice are transgenic. Similarly, the use of the words 
“while/whereas” may create difficulties. While implies a strict temporal linkage (at the 
same time as). Incorrect usage: “I started the experiment while she finished it.” Cor-
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rect usage: “Caesar fiddled while Rome was in fire.” “Needless to say” why then to 
say. “Remarkable” is not a synonym for “marked”, it is more. “Employ” (used as a 
synonym for “use”) implies salary payment. “Parameter” use “variable.” Use “rela-
tively” only when comparing. “Filled symbols” not “solid symbols”. “Quite” is quite 
unnecessary. “Varying” is often used in the meaning of “various”. “Before” is better 
than “prior to” (the latter is commonly used by Americans). “In the present communi-
cation” use “here”. “As can be seen from Fig. 2, growth is more rapid”, make it sim-
pler and use an active voice: “Growth is more rapid (Fig. 2)” or “Fig. 2 shows that 
growth is more rapid”. “Significant”, use only when related to statistical analyses. 
“From the standpoint of” read “according to.” “Approximately” better “about.” “In 
comparison with” not “in comparison to.” “Begin or start” are better than “com-
mence” (the latter is commonly used by Americans). “Considerable amount of” actu-
ally means “much”. “Created the possibility” replace by “Made possible”, “Enabled 
(a person)” or “Allowed (an action),” “Murine” means rat or mouse, not only mouse. 
“Usage” is not synonym for “use”. The former has a very limited use: “Language us-
age” whereas “use” is “widely used,” 
 
10.2. Singular/plural and numbers 
 “About 10 g was added” not “About 10 g were added” as only one unit was 
added. If the addition would occur in doses of 1 g then “About 10 g were added.” 
Latin-derived words ending with “a” (“data, media”) are plural: “Data are expressed 
as means ± S.D.” Numbers 1 to 9 are written as words, 10 and up as numbers. “Three 
experiments” and “13 experiments.” Exception, when a number is followed by a unit: 
“3 ml” and “13 ml.” A sentence is not started with a number: “Reagent A (5 ml) was 
added.” When a number is written as a word, the following unit is not abbreviated: 
“Five milliliters of reagent A was added.” 
 
10.3. Nouns as adjectives/adjectives as nouns 
 The following is a bad example of the use of several consecutive nouns as adjec-
tives. “Rat liver polyamine oxidase activity.” “Hepatic disease” is better than “Liver 
disease” and “Administration of drug” is better than “Drug administration.” Latin-
derived words “in vitro, in vivo, de novo” are not used as adjectives. “Tests in vitro” 
not “In vitro tests.” The word “supernatant” is usually an adjective: “100,000 x g su-
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pernatant fraction” is better than “100,000 x g supernatant.” Natural genotype is 
“wild type” but when used as an adjective “wild-type mice.” 
 
10.4. Abbreviations 
 Abbreviations are never used in the title and their use should also be avoided in 
the Summary. The word or phrase is first written in full following abbreviation in pa-
renthesis: “Ornithine decarboxylase (ODC).” Many journals allow the use of abbre-
viations only when the word or phrase appears in the text five or more times. The 
journals usually have an “official” list of abbreviations (RNA, DNA, ATP etc), which 
can be used without writing the word first in full. Abbreviations can be avoided by 
using pronouns (“it, they, them”) or substitutive expressions (“the inhibitor, the sub-
strate, the drug”). The abbreviation “i.e.” means that is whereas “e.g.” means for ex-
ample. 
 Units are abbreviated when used with numbers (“4 mg was added”) and the ab-
breviation is the same in the singular and plural. Units are not abbreviated when used 
without numbers: “Specific activity is expressed as nanomoles of GTP incorporated 
per milligram of protein per minute.” 
 Note the use of indefinite article: “A Master of Science degree” but “an M.Sci. 
degree.” The latter abbreviation is read as “em ess” (begins with a vowel). The ge-
neric names of organisms are first written in full “Staphylococcus aureus” and subse-
quently abbreviated “S. aureus.” 
 University degrees are written in American English with dots: “M.Sc., M.D., 
Ph.D.” whereas in British English without dots: “MSc, MD, PhD.” 
 
10.5. British versus American English 
 The spelling of many words is slightly different in British and American English. 
In most instances, the American spelling is usually a bit simpler. British “ou” is re-
placed by “o” in American English: “tumour” vs. “tumor”, “behaviour” vs. “behav-
ior." Similarly, the British “ae” is replaced by “e” in American English: “anaemia” 
vs. “anemia,” “anaesthesia” vs. “anesthesia.” The British double l “ll” is usually re-
placed by single l “l”. “labelled” vs. “labeled”, “signalling” vs “signaling.” The last 
two words are typically misspelled when one tries to write American English. A typi-
cal difference is also the use of the endings “re” and “er”, of which the former repre-
sents British English: “centre” vs. “center”, “litre” vs. “liter.” In British English, cer-
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tain verbs contain “ys” corresponding the American “yz”: “analyse, catalyse, dialyse” 
vs. “analyze, catalyze, dialyze.” Finally, an interesting difference: “In British English 
periods and commas are outside the quotations marks”. “In American English they 
are inside the quotation marks.”  When writing English, be consistent with the varia-
tion. 
 
10.6. Greek alphabets 
 As the Greek alphabets are frequently used in scientific writing, their tabulation 
helps a lot for finding the correct symbol. The table below lists Greek alphabets, their 
pronunciation and the corresponding Roman alphabet. 
Greek alphabets: 
 
A a       alpha          a           N n    nu        n 
B b       beta            b             X x       xi              x 
G g        gamma       g,n           O o      omicron   o 
D d        delta           d        P p      pi             p  
E e        epsilon        e        R r        rho          r,rh 
Z z        zeta             z             S s     sigma      s 
H  h       eta               ê              T t        tau          t 
Q  q       theta           th             U u      upsilon   y,u 
I i         iota              i               F  f       phi          ph 
K k       kappa         k              C  c      chi           ch 
L l       lambda       l               Y y      psi          ps 
M m    mu          m              W  w      omega    ô 
  
 
 Familiar examples are: a-adrenergic, b-sheet, DNA polymerase d, k-casein, l-
phage, mM, s-factor, c-square. 
 
10.7. Useful phrases 
 The scientific literature is packed with useful phrases, which can be used to enli-
ven one’s text and a to avoid repetitions. The following examples have been picked 
up from the scientific literature by the author over a period of two decades. The genes 
of capsule: “The genes governing capsule synthesis…” It is known: “It is now com-
mon knowledge that ...” Current interest: “…are currently focused on…” Matched; 
“Is compatible with life.” In spite of a lot of work: “Despite the expenditure of  a great 
deal of effort…” We know little: “Our knowledge of this crucial subject is still in its 
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infancy…”. Experimental limitations: “The limitations inherent in the experimental 
method employed..” Caution should be exercised: “There is reason for caution in in-
terpretation…” More distrust: “There is growing suspicion that…” Avoid difficulties: 
“This difficulty can be circumvented by…” Ungrounded conclusions: “Unwarranted 
mechanistic implications…” Is known: “Awareness of the events…” Not certain: 
“There is no assurance that replacing Mg++ by polyamine can…” Uncertain results: 
“The result should be considered suggestive, at best, since the group studied was 
small.” Something has to be done before: “A more global view of the subject should 
be obtained before embarking on such an undertaking,” Not fully proven: “Lack of 
categorical proof.” Not proven: “…is unproven on present evidence.” Weak conclu-
sions: “The validity of these conclusions is in serious doubt due to two main fac-
tors…” Restrictions: “But within such critical limitations, these studies did indicate 
that…” Causing: “A direct cause-effect sequence…” Warranted: “It is based on rea-
sonable logic.” Doubtful: “There is good reason to suspect that…” Drug doses: 
“…occurs in clinically relevant dosage ranges…” Similarly: “In analogous fashion.” 
Doubtful mechanism: “The mechanism involved remains the subject of controversy.” 
Not obvious: “It is not immediately apparent how this would lead…” Unclear: “…is 
still a matter of debate.”  Bad planning: “Suffering greatly from poor design,”  Most 
important issues: “…only to summarize salient features…” Limit the discussion: 
“…and confine discussion to their possible functions.” Return to the beginning: “Let 
me refer back to the beginning of this review.” Uncertain: “We are by no means cer-
tain that…” Remove of differences: “Differences were minimized or abolished.” One 
can ask: “The question can be posed only as to…” Doubtful results: “…remains 
clouded by reports of conflicting data.” Hopefully tells: “It is hoped that this overview 
depicts the status of our current knowledge.” Answers only after we know: “The an-
swers to these and other questions may come only after we have much better perspec-
tive about how membrane transport occurs at molecular level.” Challenging lack of 
knowledge: “This lack of knowledge should not be looked upon negatively but seen 
instead as a challenge.” Incomplete data: “…although data are not as complete as 
one might wish.” Unsuccessful: “…would appear to be doomed to failure.” Getting 
worse: “…appear to make a bad situation immeasurably worse.” Not dealt with spe-
cifically: “A matter not specifically addressed in this review is the question as to what 
extent…” Two enzymes act together: “Through the concerted action of two enzymes.” 
Not expected: “Lack of significant progress would be the expected outcome.” Sup-
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ports the view: “Has lent credence to the view.” Conclusions: “Three other conclu-
sions derived from this experiment.” Weak evidence: “The stringency of the evidence 
varies in quality.” Not an extensive coverage: “The reader should not expect and en-
cyclopedic coverage of the entire literature, but a treatise of selected topics.” Prelimi-
nary evidence: “The accumulated evidence is still tentative.” Soon: “…followed not 
long thereafter”. Focused on transgenic mice: “In this review particular attention will 
be devoted to recent transgenic mouse experiments that…” The last example ap-
proaches already the borders of good sense of style: “Once the wrinkles in the tech-
nique have been ironed out, researchers…” 
 
11. Tips for statistical analyses 
 
 Statistical analyses occupy a central position in the preparation of scientific article 
and the significances of differences (or better the lack of those) may profoundly influ-
ence the acceptance of the paper. It is not the intention of this text to deal with basics 
of the statistics, but rather give practical tips for statistical analyses. The performance 
of statistical analyses today is very easy, as a large number of statistical software 
packages are available. These packages usually are so user-friendly that a researcher 
with no formal statistical training easily can perform the analyses. However, there are 
certain basic issues that have to be understood when carrying out the analyses in gen-
eral and interpreting the results in particular. For the example analyses, I have chosen 
GraphPad Prism (GraphPad Software, Inc., San Diego, CA, U.S.A.) software pack-
age. This package is extremely user-friendly with very good graphics. Only those sta-
tistical tests that I have needed during my research career are included. 
 
11.1. Before statistical analyses 
 A central issue in the interpretation of analyses and experimental results is the 
fact that statistical significance is not equal to biological or clinical importance. A sta-
tistically highly significant difference between experimental groups does not auto-
matically mean that this difference would be biologically or clinically relevant. For 
instance, a decrease in a few millimeters of mercury of systolic blood pressure in re-
sponse to treatment may be statistically highly significant, yet it hardly has any clini-
cal relevance. Unfortunately, the statistical significance of a difference is often em-
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phasized without considering its practical relevance. On the other hand, even a very 
large difference between experimental groups but without statistical significance may 
create problems in publishing the results. The enclosed example would hopefully il-
lustrate the problem. In the figure A, the difference between the two groups is mini-
mal, yet highly significant. In figure B, the difference between the groups is many-
fold but not statistically significant. I would believe the case B and increase the sam-
ple size, e.g. number of animals per group. 
 
11.2 Variability: Standard deviation or standard error of the mean? 
 Standard deviation (S.D.) quantifies the scatter, i.e. the variability between values. 
In principal, the change of S.D. cannot be predicted upon increase in the sample size 
(yet, it usually decreases). Standard error of the mean (S.E.M.) indicates how accu-
rately the true mean of the population is known. S.E.M. decreases when the sample 
size increases. If the scatter is attributable to biological variation, S.D. is used. In sys-
tems in vitro with no biological variability (series of enzyme assays, for instance), 
S.E.M. is used as the scatter is caused by experimental imprecision. Some scientists 
exclusively use S.E.M. as it is always smaller than S.D. (S.E.M. = S.D./÷n). The 
common belief that one should be consistent and use either S.D. or S.E.M. is not nec-
essarily true as the source of the variability, biological or methodological imprecision, 
determines their use. 
 
11.3. Outlier (abnormal value) 
 An experimental value that is far from the other values is called an outlier. There 
may be trivial reasons for abnormal values, such as incorrect data entry into a com-
puter or funny-looking test tube or strange animal etc. In such cases the abnormal 
value can be corrected or omitted. However, the possibility remains that the outlier is 
Control Experimental0
5
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**
A.
Control Experimental0
20
40
60
80 Not significant
B.
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derived from entirely different population (e.g. sick animal among healthy popula-
tion). Statistically it is possible to detect whether the value is derived from different 
population or distribution and omit it “legally”. The value is standardized by dividing 
the difference between the mean value and the outlier by scatter (S.D.) yielding Z 
value. This is called Grubbs´ test (see the enclosed example). In Gaussian distribution, 
only 5 % of the values are more than 1.96 x S.D. from the mean. If the Z value is 
more than 1.96, the abnormal value is an outlier (p < 0.05) and comes from different 
population. If N is small (see the table) the critical value is less than 1.96. After com-
puting Z value, compare the value with critical values of the table at given N. If the 
value is greater than the critical value, the abnormal value is derived from a different 
population with the probability of p < 0.05. 
 
11.4. Comparing two groups: Parametric tests: t test  
 The name of the t test is derived from a British statistician who wrote under the 
pseudonym “Student” (“Student’s test”). The test is by far the most common statisti-
cal test used to compare two means. In fact, the test analyses whether a difference be-
tween two means differs from zero. The significance is influenced by the magnitude 
of the difference and the scatter within the groups. 
Paired t test: Paired t test is used when a variable is measured before and after some 
intervention (e.g. drug) in the same person or animal. The test is likewise used when 
patients are enrolled pair-wise: same age, equal severity of the disease etc. One of the 
Z = taulukko 
3 1.15
4 1.48
5 1.71
6 1.89
7 2.02
8 2.13
9 2.21
10 2.29
11 2.34
12 2.41
13 2.46
14 2.51
15 2.55
16 2.59
17 2.62
18 2.65
19 2.68
20 2.71
30 2.91
50 3.13
100 3.38
N Z
Example
  Fat percentage of the mice:
    2.12, 1.80, 2.09, 2.28, 2.47
    and 4.1
  Mean ± S.D.:
    2.48 ± 0.83 (N=6)
  Is 4.1 an "outlier"?
Z =  
[2.48-4.1]
0.83 =
1.95
  Critical value for Z
    (N=6) is 1.89, accordingly
    4.1 is an "outlier"
Z table
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pairs will be treated, the other not. Similarly, the paired test will be used when a labo-
ratory experiment is repeated several times with control and experimental group. 
Unpaired t test: This test is used when two independent groups are compared. For in-
stance, two animal groups, of which one group is exposed to a drug and the other 
group remains untreated. 
 t Test can be either one-tailed or two-tailed. The former uses only one of the tails 
of the Gaussian distribution whereas both tails are used in the latter. One-tailed test 
can only be used when there is justifiable (prior) knowledge that the mean of one 
group is larger or smaller than that of the other. In comparison with the two-tailed 
test, this test gives p values that are half of those of the two-tailed test. The two-tailed 
test is used in the vast majority of analyses. Below is an example of the performance 
of unpaired t test. 
 
 t Test is a parametric test, which assumes that both groups follow bell-shaped 
Gaussian distribution (normal distribution) i.e. the variances (S.D.2) of the groups do 
not differ significantly. The computer program in the enclosed example, as most of 
the statistical programs, automatically compares the variances (F test) and reports any 
significant difference between them. As shown, the variances in the example do not 
differ significantly. If the variances are significantly different  (or the data are 
ranked), nonparametric tests must be used. Giving certain significant limits (*p < 
0.05, **p < 0.01 and ***p < 0.001) for p values dates back the to era without comput-
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Parameter Value
 Table Analyzed t-test
 Column A Wild type
vs
 Column B Transgenic
 Unpaired t test
  P value 0.0051
  P value summary **
  Are means signif. different? (P < 0.05) Yes
  One- or two-tailed P value? Two-tailed
  t, df t=3.564 df=10
 How big is the difference?
  Mean ± SEM of column A 24.17 ± 1.759 N=6
  Mean ± SEM of column B 34.33 ± 2.246 N=6
  Difference between means -10.17 ± 2.853
  95% confidence interval -16.52 to -3.810
  R squared 0.5595
 F test to compare variances
  F,DFn, Dfd 1.630, 5, 5
  P value 0.6048
  P value summary ns
  Are variances significantly different? No
Example:
< Mouse weight (g):
< Wild type: 23,
     31, 21, 27, 24 ja 19
< Transgenic: 36, 29,
     27, 34, 41 ja 39 
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ers. The exact value of p (p = 0.0051 in the example) can be given as well. Parametric 
tests are more powerful (smaller p values) than nonparametric tests. Before the use of 
nonparametric tests, the data can be transformed (reciprocal, logarithmic) to possibly 
achieve normal distribution. 
 
11.5. Nonparametric tests: Mann-Whitney test 
 As mentioned, parametric tests cannot be used if the variances differ significantly 
or the data are ranked. Below is an example of the former i.e. variances differ signifi-
cantly. 
 
 As seen, F test finds a significant difference between the variances of the two 
means excluding the use of t test. As the groups in the example are independent, the 
nonparametric test of choice is Mann-Whitney test. The test ranks all the values from  
 
Example:
Group A, value   33   24   9   32   6
Group B, value     1     8   7     4   5
t-test
Unpaired test
P value 0.0261
P value summary *
Are means signif. different Yes
One-or two-tailed P value Two-tailed
t, df  t=2.724  df=8
F test to compare variances
F, DFn, Dfd   21.43, 4.4
P value 0.0058
P value summary **
Are variances significantly
different Yes
< Compare two groups (A and
     B)
< Perform t-test
Group A, value        33   24   9   32   6  S
Group A, rank         10     8   7     9   4  38
Group B, value          1     8   7     4   5
Group B, rank           1     6   5     2   3  17
Ryhmä A Ryhmä B0
10
20
30
*
Mann-Whitney test
P value  0.0317
P value summary  *
Are medians significantly 
different (p<0.05)  Yes
One-or two-tailed P value  Two-tailed
Sum of ranks in column A,B 38,17
Example:
< The test ranks the values
Group A Group B
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low to high (paying no attention to the different groups). The smallest value gets the 
rank of one and the largest value the rank of N (total number of the values in the two 
groups). The test computes the sum of ranks for both groups. The larger the difference 
is between the groups, the smaller p becomes. The test is not suitable for very small 
groups as if the total sample size is less than seven the p value becomes automatically 
larger than 0.05 irrespective of the difference between the means. Even though non-
parametric tests are less powerful than parametric tests, nonparametric tests have the 
advantage that they are insensitive to outliers because absolute values are not used. 
Accordingly, outliers may remain. Although in the example, the values were ranked 
manually, this is not necessary as the program does it automatically. Absolute values 
are entered into the computer. Note that the p value is substantially higher than in the t 
test. 
 
11.6. Nonparametric tests: Wilcoxon test 
 This test corresponds paired t test and is also called matched pairs test. This test 
computes the absolute differences between each pair, ranks them from low to high 
and sums the ranks. If the difference between the rank sums is large, the p value is 
small. Finally, the test computes whether the medians of the groups differ signifi-
cantly from each other. 
 
 
 
1 20
20
40
60
80
100
120
Measurement
m
m
  H
g
n.s.
Example:
Person           Reading 1    Reading 2   Difference
    A    120    110           -10 2
    B      80      95            15 3
    C      90    120            30 5
    D    110    130            20 4
    E      95    100              5 1
Systolic blood pressure (mm Hg)
Wilcoxon test
P value 0.1875
P value summary ns
Are medians significantly
different (p<0.05)? No
One- or two tailed P value? Two-tailed
Sum of negative, positive
ranks -2.000, 13.00
Reading
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11.7. Comparing three or more groups: One-way analysis of variance (ANOVA) 
 As mentioned, t test and the corresponding nonparametric tests can only be used 
to compare two different groups. In case that there are three or more groups, it is ille-
gitimate to use t test to compare control group, for instance, separately with each ex-
perimental group. The proper test for three and more independent groups is analysis 
of variance (ANOVA). If there is only one grouping variable, the test is called one-
way ANOVA. ANOVA is a parametric test that assumes a Gaussian distribution. 
With two groups one-way ANOVA is equal to t test. With three or more independent 
groups, ANOVA only reports whether there is statistically significant difference be-
tween the groups but does not compare individual groups. For multiple or pair-wise 
comparisons, several post hoc test are available. 
 Below is an example of the performance of one-way ANOVA. 
  
As indicated in the example, ANOVA finds out a significant difference between 
the four groups but does not compare individual groups. 
 
11.8. Post hoc tests for ANOVA 
 Post hoc tests can only be used if ANOVA detects an overall significant differ-
ence between the groups. All the post hoc tests are variations of t test. 
Dunnett’s test: Compares control (or any individual) group with other groups. 
Bonferroni test: Compares selected pairs of groups or all pairs of groups. The distinct 
disadvantage of Bonferroni test is the fact that the test is very conservative (large p 
values). This does not matter when the number of the groups is small, but large num-
Control Arg Arg+drugx1 Arg+drugx2
0
5000
10000
15000
20000
25000
30000
35000
Pl
as
m
a 
am
yl
as
e 
ac
tiv
ity
ANOVA p < 0.001
Example:
Control     Arg       Arg+drugx1    Arg+drugx2
2309       15580           2059              1698
1410          32040           2020              1798
1800       33980           6529              1715
                                       3168
<Effect of arginine on plasma amylase activity
One-way ANOVA
P value 0.0003
P value summary ***
Are means significantly
different? Yes
Number of groups 4
F 19.51
R squared 0.8667
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ber (more than five) of groups creates problems. If the limit of significance has been 
set to p < 0.05 this will be divided by the number of comparisons (e.g. in case of 10 
comparisons, the limit of significance decreases to p < 0.005). In the following exam 
ple of Dunnett’s post hoc test the control group has been compared with experimental 
groups and it significantly differs only from the Arg group. In the example of the Bon-
ferroni test, all groups have been pair-wise compared with each other. 
The Bonferroni test indicates that both of the drug-treated groups differ highly signifi-
cantly from the untreated (Arg) group. 
 Tukey and Newman-Keuls tests are nearly identical further post hoc tests for 
ANOVA. They are related to the Bonferroni test. 
 
11.9. Nonparametric tests: Kruskal-Wallis test 
 This test is used for comparison of three or more independent groups when the 
data are either ranked or the variances of the groups differ significantly from each 
other. As in other nonparametric test, each value is ranked so that the smallest value 
gets the rank of one and largest value the rank of N (total number of observations). 
The ranks are summed. The larger the difference of rank sums is, the smaller p value. 
The test is also called “Kruskal-Wallis one-way ANOVA by ranks”. 
 
11.10. Nonparametric tests: Friedman test 
 This test is used for comparisons of three or more paired groups. The principle of 
the test is identical to that of Kruskal-Wallis, i.e. the pairs are ranked and the ranks are 
summed for each group. The test is also called “Friedman two-way ANOVA by ranks 
(repeated measures)”. 
Dunnett´s post hoc test
Control vs Arg -25360 p<0.01
Control vs Arg+drugx1   -1604 p>0.05
Control vs Arg+drugx2       102.7 p>0.05
Mean diff. P value
Control Arg Arg+drugx1 Arg+drugx2
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p < 0.001
p < 0.001
Bonferroni´s post hoc test
Control vs Arg -25360 6.306 p < 0.001
Control vs Arg+drugx1    1604 0.4264 p > 0.05
Control vs Arg+drugx2     102.7 0.02553 p > 0.05
Arg vs Arg+drugx1 23760 6.315 p < 0.001
Arg vs Arg+drugx2 25460 6.331 p < 0.001
Arg+drugx1 vs Arg+drugx2  1707 0.4537 p > 0.05
Mean diff. t P value
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11.11. Two-way ANOVA 
 The test determines how a given response is influenced by two different variables, 
i.e. there are two grouping variables (in one-way ANOVA only one grouping vari-
able). For example, the effect of three different drugs on persons of different gender. 
The test answers three questions: (i) Are the average responses identical to all drugs? 
(ii) Are the responses same in men and women? (iii) Do the factors interact: is the dif-
ference between men and women same with all drugs? 
 So-called “Repeated-measures two-way ANOVA” is a convenient test when the 
effect of a drug is followed as the function of time, for instance. The measurements 
are repeated continuously as the function of time in the absence or presence of the 
drug. The test finds out whether the curves differ significantly from each other. The 
curves can also be compared by computing the areas under the curves (“AUC”). Re-
peated-measures two-way ANOVA can also be used when persons are enrolled as 
matched pairs (age, gender, disease etc) or when a laboratory experiment is repeated 
several times (with control and treated groups). The difference between ordinary 
ANOVA and repeated-measures ANOVA is the same as the difference between un-
paired and paired t test, i.e. the latter is more powerful (smaller p values). 
 The following example depicts an experiment where cell growth has been fol-
lowed for four days in the absence or presence of a potentially cytotoxic drug. The  
 
samples have been taken as triplicates at each time point. The analysis reveals that the 
curves differ highly significantly, i.e. the drug significantly inhibits cell growth. The 
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p < 0.001 ANOVA
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Example:
Time (h)   Control       +Drug
0 0.62;0.58;0.51    0.69;0.58;0.62
24 1.2;1.0;1.3     0.9;0.82;0.75
48 1.4;1.6;1.7     0.95;1.0;1.1
72 2.8;2.6;2.3     1.32;1.22;1.40
96 4.0;3.9;4.2     1.28;1.40;1.35
< Cell densities
Two-way ANOVA
(repeated measures)
Source of variation   % of total variation P value
Interaction 22.99 p < 0.001
Time 53.47 p < 0.001
Column factor (drug) 22.47 p < 0.001
Does the column factor affect the result? (Are the curves different?)
The P value is < 0.001. The effect is considered extremely
significant.
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significance of the differences at each time point could be computed by using un-
paired t test but it can also be tested using the Bonferroni post hoc test as shown in the 
example below. There is a significant difference between all time points except the 
first ones. 
 
  
 11.12. Linear regression 
 Linear regression analyzes the relationship between two variables (X and Y). The 
test finds out the best straight line through the data points. The course of the line is 
determined by the slope and the intercept (at Y or X-axis). The line can also be used 
as a standard curve to obtain new values of X from Y or Y from X. It is possible to 
transform nonlinear data to obtain a linear relationship. Familiar examples are 
Lineweaver-Burk plot (reaction velocity versus the reciprocal of substrate concentra-
tion; v versus 1/[S]) and Scatchard transformation for ligand binding affinity 
(bound/free ligand versus bound ligand).  
 The analysis computes r2 value, which indicates the “goodness” of the fit. The 
value is without dimensions between 0 (horizontal line) and 1.0 (all points on the 
line). In the best fit, the line minimizes the sum of squares of the vertical distances of 
the points from the line. F test computes the p value for the relationship by taking into 
account the r2 value and the number of points. 
 The strange name (regression) is apparently derived from the first applications of 
the analysis where lengths of fathers and their sons were compared. The results of the 
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******
Bonferroni´s post hoc test
Column factor Difference P value
0 0.0600 p > 0.05
24                   -0.3433 p < 0.05
48                   -0.5500 p < 0.01
72                   -1.253 p < 0.001
96                   -2.690 p < 0.001
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analyses revealed that the sons of tall fathers were shorter than their fathers. In other 
words, the sons of the tall fathers were “regressed”. 
 As indicated in the example analysis below, a very close (r2 = 0.9801) and highly 
significant (p < 0.001) correlation exists between X and Y. 
 
 
11.13 Contingency tables 
 Contingency tables compare categorical variables, e.g. dead versus alive, disease 
versus no disease, artery obstructed versus artery open. The results of a given experi-
ment may not be fully accordant with the theoretical distribution and the question is 
posed as to whether the difference between the expected and observed distribution is 
greater than that caused by random variation. The test used are c2 (Chi squared) test 
and its modifications. The simplest contingency table is a 2 x 2 table (two variables 
determining the two columns and two rows). The columns determine the outcomes 
and the rows the groups. In the following example, in which the effect on mortality of 
a drug has been tested, the variables are wild-type versus transgenic animals and the 
categorical variables are dead or alive The data in this kind of table can be analyzed 
with c2 test, for which Yate´s continuity correction can be adapted or using Fisher’s 
0 25 50 75 100 125 150
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X
Y
r2 = 0.9801
p < 0.001
Best-fit values
     Slope 0.9139 ± 0.05313
     Y-intercept when X=0.0   -21.12 ± 4.080
     X-intercept when Y=0.0    23.11
     1/slope 1.094
    95% Confidence Intervals
     Slope 0.7839 to 1.044
     Y-intercept when X=0.0   -31.10 to -11.14
     X-intercept when Y=0.0    13.95 to 30.34
    Goodness of Fit
     r squared      0.9801
     Sy.x 4.826
     Is slope significantly non-zero?
     F 295.9
     DFn, DFd 1.000, 6.000
     P value < 0.0001
     Deviation from zero? Significant
   X  Y
  24   9
  37 12
  48 19
  58 26
  72 43
  92 61
105 78
122 93
Example:
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exact test. The latter gives the exact value for p and is hence recommendable unless 
the sample size is very large (thousands). 
Below is an example of a 2 x 2 contingency table. Note that the p values for each 
modification are slightly different. 
 
11.14 Survival curves (Kaplan-Meier) 
 In many experiments, the end point is death or any event occurring only once (re-
jection of a transplant, obstruction of an artery etc). The end point does not need to be 
negative (discharge from hospital, graduation etc). Kaplan-Meier survival curves de-
termine the occurrence of the end point as the function of time. In GraphPad Prism 
program, data is entered in such a way that X represents the time (week, month) until 
the end point. The end point is entered as Y = 1 at the corresponding time. Any drop-
out (out of control) is entered as Y = 0 (censored data). For instance, if a survival  ex-
periment is concluded after a certain time period, all animals still alive will appear as 
Y = 0 at the last time point of observation. The following example shows the entry of 
the data derived from a survival experiment. The total observation period was 79 
weeks. Of 12 control mice (WT), one died at week 59, the remaining mice were still 
alive at the time the experiment was concluded (week 79). All mice of the two trans-
genic groups (MT-SSAT and SSAT) died before the end of the observation period. 
Logrank test is used to compare two or more groups. The test compares at each time 
point the expected and observed number of end points, collects the values into a c2 
Example:
< Effect of drug
Group          Dead               Alive
Wild type 18 12
Transgenic       8 22
Fischer´s exact test
P value 0.0182
P value summary *
One- or two-sided Two-sided
Chi-square
Chi-square, df 6.787, 1
P value 0.0092
P value summary **
One- or two-sided Two-sided
Chi-square with Yate´s correction
Chi-square, df 5.498, 1
P value 0.0190
P value summary *
One- or two-sided Two-sided
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(Chi square) table and computes the p value. In case of three or more groups, the test 
calculates the trend. 
 The examples below show the entry of the data and the results of a survival ex-
periment consisting of three groups. 
 
 
11.15. Choosing the statistical analysis 
 Fig. 4 outlines the selection of the statistical tests for two (A) or more (B) groups. 
The first question would be the type of analysis, i.e. whether parametric or non-
parametric analyses will be used. If the variances of the groups are significantly dif-
ferent or the data are ranked, parametric tests are excluded and nonparametric tests 
should be used. Categorical variables require the use of contingency tables or Kaplan-
Meier survival curves, if there is a time function. Searching for correlation between 
the variables implies the use of linear regression. Unpaired or paired t tests are used 
for the analysis of two groups with Gaussian (normal) distribution whereas groups 
with ranked data or unequal variances will be analyzed with Mann-Whitney test (un-
paired data) or Wilcoxon test (paired data). For three or more groups with Gaussian 
distribution, ANOVA will be the analysis of choice. One-way ANOVA is used when 
there is only one grouping variable and two-way ANOVA when there are two group-
Week            WT             MT-SSAT         SSAT
59 1
79 0
79 0
79 0
79 0
79 0
79 0
79 0
79 0
79 0
79 0
79 0
26 1
37 1
57 1
57 1
59 1
70 1
72 1
43 1
44 1
58 1
59 1
59 1
66 1
66 1
68 1
74 1
75 1
X Y1 Y2 Y3 Comparison of Survival Curves
Logrank Test
Chi square 24.10
Df   2
P value   0.0001
P value summary ***
Logrank test for trend
Chi square 17.14
Df   1
P value   0.0001
P value summary ***
0 10 20 30 40 50 60 70 80 90
0
50
100 Wild type
MT-SSAT SSAT
p<0.001
(median=57 w) (median=62.5 w)
Weeks
Pe
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l
 56 
ing variables. The corresponding nonparametric tests for three or more groups are 
Kruskal-Wallis test (unpaired data) and Friedman test (paired data). 
 
 
 
 
 
 
 
 
 
       Fig. 4. Choosing the statistical test. A, two groups; B, three or more groups. 
 
12. Writing a grant proposal 
 
 Writing a successful grant proposal is probably one of the most creative but also 
most demanding tasks for a scientist. A grant proposal combines in its research plan 
earlier and present work with new ideas and hypotheses. A grant proposal contains 
almost all central features of science, such as creative conceptualization, detailed ex-
perimental and budgetary planning, projection and analysis of the anticipated results 
and even a rescue plan for unexpected outcome. Even though a scientific paper and a 
grant proposal have much in common, there is a fundamental difference between 
them: the former tends to sell obtained results whereas the latter tends to sell new re-
search ideas. This fact profoundly influences the preparation of a grant proposal as 
credibility, i.e. that the applicant is able to complete the proposed research, becomes a 
central issue. 
 
12.1. Organization of the research plan 
 Research plan is by far the most important part of the grant proposal. Nearly all 
funding agencies use a very similar format for the research plan, which largely has 
been adapted from that used by the National Institutes of Health (NIH) in the U.S.A. 
The research plan usually consists of the following components: 
1. Abstract (Summary) 
   2  groups
Normal distribution
Unpaired Paired
t test
(unpaired)
t test
(paired)
Mann -Whitney
test
Ranking/
different 
variances 
UnpairedPaired
 
Wilcoxon
test 
Kaplan-Meier/
logrank 
Contingency -
tables /c2 test
Linear
regression 
A.
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Nonparametric analyses
Parametric analyses
  >2  groups
Normal distribution
   One grouping variableTwo grouping variables 
One-way
ANOVA
Two-way
ANOVA
Post hoc
tests 
Ranking / 
variances 
different 
UnpairedPaired
Kruskal-Wallis
test 
Friedman
test 
Kaplan-Meier/
logrank 
Contingency
    tables/c2 test
Linear
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Nonparametric analyses
Parametric analyses
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2. Background and significance 
3. Objectives, approaches and methods 
4. Research group and resources 
5. Results 
6. Budget and budget justification 
The length of the research plan is most commonly limited to 10 pages. Most funding 
agencies are very strict in this respect. 
 
12.2. Title 
 The title should describe the central aim or concept of the proposed project. It 
should neither be too specific nor too general. In the latter case, feasibility of the pro-
posal can be doubted (especially if the funding period is short). The reviewers for the 
proposal are usually selected on the basis of the title and/or the Summary. The title 
should be short giving a good description of the proposal. 
 
12.3. Abstract (Summary) 
 The Abstract is probably the most important part of the research plan as the re-
viewers of the proposal read this first and if there are large number of applications, the 
Abstract may be the only part of the proposal to be read. The Abstract is likewise used 
to select the appropriate reviewers for the proposal. The Abstract of a research plan is 
not equal to the Summary of a primary paper. The project abstract describes what will 
be done and why it is important and not what has been done and why it was impor-
tant. The Abstract does not contain results, though the previous work of the applicant 
in the field should be strongly emphasized. The Abstract almost never is longer than 
one printed page. 
 A proper organization of the Abstract is very important. Relate the proposal to a 
broader context and show possible gaps in current knowledge: “Pancreatitis is a life-
threatening disease, the exact pathophysiology of which is largely unknown.” De-
scribe your earlier work relevant to the proposal: “We recently developed a transgenic 
rat model for acute pancreatitis that closely resembles the human necrotizing dis-
ease." Present the research problems and hypotheses to be tested. “The main aim of  
the present proposal is test whether treatment modalities effective in our transgenic 
model are also applicable to other models of acute pancreatitis.” Describe where and 
how the study will be carried out and what kind of methodological approaches will be 
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used: “ The study will be carried out at the A.I. Virtanen Institute for Molecular Sci-
ences, University of Kuopio. The analogues proven to be effective in our transgenic 
model will be tested in cerulein and arginine-induced pancreatitis. The effect of the 
drugs will be assessed by general mortality rate, histopathology and plasma amylase 
activity.” Finally, assess the potential significance of the results in a broader context 
and do not be too modest: “This study will be of unique value in designing new treat-
ment modalities for acute pancreatitis.”  
 
12.4. Background and significance 
 This section resembles the Introduction of a primary paper but it is structured in a 
slightly different way. Place the proposal in a broader context by citing the most im-
portant publications in the field in general and your own previous published work 
relevant to the proposal in particular. It is of utmost importance to bring up your pre-
liminary (unpublished) experiments supporting the proposal and giving credibility to 
it. You may present these preliminary experiments under a special subheading: “Own 
preliminary results.” It is, however, highly advisable to strictly adhere to the truth as 
this part commonly contains scientific exaggeration and conclusions that are based on 
qualitatively or quantitatively poor preliminary experiments. Finally, you assess the 
general contribution of the results to be obtained to this particular field of research 
(“Significance”). 
 
12.5. Objectives, approaches and methods 
 The most important aim of this section is to convince the reviewers and the fund-
ing agency that the applicant has a realistic and feasible research plan. The sequence 
objectives-approaches-methods stepwise focuses the performance of the study from 
central aims to specific methods. Objectives represent the general aims of the study in 
the particular field of research. Approaches represent the strategic use of techniques 
and methods stand for the use of specific methods. The credibility of the research plan 
is strengthened by giving an appropriate reference for each method and even more by 
stating that the method is already in routine use in the laboratory. The proposed meth-
ods should naturally be relevant to the resources of the laboratory (see also Research 
group and resources). 
 This section also contains the timetable with possible milestones. The inclusion of 
a time schedule of the study belongs to the credibility issues and also helps the appli-
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cant to outline the performance of the study and its progression. As an example of an 
entirely unrealistic research plan was a proposal to generate gene-disrupted mice 
within one-year funding period in a laboratory with no prior experience. Setting up 
milestones within the funding period likewise strengthen the credibility of the re-
search plan. The milestones can easily be presented in a form of time chart. 
 This section also contain ethical issues, such as the appropriate approval of ani-
mal experiments (Institutional Animal Care and Use Committee) and approval of hu-
man trials (Institutional Review Board and Informed Consent). It should be noted that 
the latter approval is not only limited to clinical trials but should also be obtained for 
analyses of samples derived from patients.  
 Some funding agencies (Academy of Finland, for instance) require that this sec-
tion contains goals for post-graduate training and hence a list of post-graduate stu-
dents aiming to the doctoral degree should be provided. 
 
12.6. Research group and resources 
 This section might as well appear under the Objectives, approaches and methods, 
in fact it mostly does, but some funding agencies (e.g. Academy of Finland) like it as 
separate section. Here, the human resources, i.e. the composition of the research 
group and special expertise of each member of the group are described. The distribu-
tion of work among the members of the group is likewise sketched. This is the place 
to present external expertise needed for the study. It should be noted, however, that 
most funding agencies require a written agreement from the collaborators. Listing the 
materialistic resources (equipment, laboratory space, cell cultures, animal facilities, 
special reagents etc) is important as it, together with used methods, helps to assess the 
feasibility of the proposal. 
 
12.7. Results 
 In this section, the anticipated outcome of the results is assessed. The expected 
results may be highly concrete, such as a creation of transgenic animals or develop-
ment of a specific therapy etc or they may be of more general nature, such as genera-
tion of new knowledge in the field. The general importance of the expected new re-
sults to the field is also assessed here and how to further exploit them. One should be 
also prepared for unexpected or even unlikely results and have a “rescue plan” ready 
for any changes in the objectives. The planned publication forums (“The results will 
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be published at the best publication forums”) and patenting issues likewise belong to 
this section. 
 
12.8. Budget and budget justification 
 A detailed budget is mostly presented in a specific form provided by the funding 
agency. The research plan usually contains only a budget summary and especially its 
justification. If the proposed research is very labor intensive, then a large salary 
budget is justified. On the other hand, if the proposal involves large number of animal 
experiments, cell culture experiments or expensive special reagents (such as needed in 
molecular biology), then a large supply budget is justified. In many cases, it is possi-
ble to apply funds for pieces of small equipment. If much travel (scientific congresses, 
meetings with external collaborators etc) is involved, it is advisable to include travel 
expenses in the original budget as changing the budget items afterwards may create 
problems or at least a permission from the funding agency is required. Finally, it is 
highly likely that the sum applied for is not received in full. 
 
12.9. References 
 The references affect the overall length of the research plan with its page limit. 
Therefore the number of references should be kept to a minimum. The style of the 
reference list and how to insert the references in the text is usually not specifically 
defined by the agency. It is advisable to choose a style that occupies as little space as 
possible, i.e.. insert the references as numbers in the text in order of their appearance. 
To save space, the titles of the references can be omitted from list, though occasion-
ally they may be of use to the reviewer. As in case with the primary paper, one should 
be careful with the correctness of the references. 
 
12.10. Curriculum vitae 
 Curriculum vitae (CV) and list of publications (complete or covering a certain 
period of time) are practically always required as appendices to the grant proposal. 
With regards to the list of publications, some funding agencies require a definite 
grouping of the publications in the list. Peer reviewed primary publications usually 
come first followed by book chapters, textbooks etc. It is not advisable to include 
submitted (not yet accepted) manuscripts in the list unless they are highly relevant to 
the research plan.  
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 The personnel register maintained by Universities may be formally official but it 
is not very reader-friendly and is probably written in the wrong language. In practice, 
all funding agencies accept an informal CV in English language, which does not need 
to be officially certified (notary public). Below is an example of a CV mostly used by 
Americans. 
 
 Name and date of birth are self-explanatory. Some times marital status is also in-
cluded. PROFESSIONAL ADDRESS: Department, University and all contact informa-
tion (phone, fax, E-mail, cell/mobile phone). EDUCATION: Graduated from School, 
Master of Science (M.Sci.); Licentiate of Medicine (M.D., qualifying examination) or 
just M.D.; Doctor of Philosophy (Ph.D.); Doctor of Medical Sciences corresponds 
usually M.D., Ph.D.; Docent or possibly Senior Lecturer. PROFESSIONAL EXPERI-
ENCE: Positions held in chronological or reverse chronological order. Instructor; Re-
search Associate; Postdoctoral fellow; Lecturer or Reader (British); Associate Profes-
sor; Professor; Dean; Member of the Board; Chairman; Chief Executive Officer 
(CEO). RESEARCH INTEREST: Three to five research topics: Transgenic animals; 
Molecular Endocrinology; Cancer research. EDITORIAL DUTIES: Editor; Associate 
Editor; Member of Editorial Board; Editorial Advisor; Ad hoc referee (list of journals 
served). MEMBERSHIPS AND AWARDS: List of Scientific Societies; Scientific and 
civil awards. MAJOR GRANT SUPPORT: List of grants and sources (years) with or 
CURRICULUM VITAE
NAME:
BORN:
Date and place
PROFESSIONAL ADDRESS:
EDUCATION:
PROFESSIONAL EXPERIENCE:
Chronological or reverse chronological order
RESEARCH INTEREST:
EDITORIAL DUTIES:
Member of Editorial Board:
Editorial Advisor:
Ad hoc Referee:
MEMBERSHIPS AND AWARDS:
MAJOR GRANT SUPPORT:
PARTICIPATION AS INVITED SPEAKER AT INTERNATIONAL
SCIENTIFIC MEETINGS:
TEACHING EXPERIENCE:
Courses given:
Doctoral theses supervised:
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without actual sums. PARTICIPATION AS INVITED SPEAKER AT INTERNATIONAL 
SCIENTIFIC MEETINGS: List of invited presentations: place, title and year. Also 
poster presentations can be listed (younger colleagues). TEACHING EXPERIENCE: 
Courses given and theses (M.Sci./Ph.D.) supervised (name, title of thesis, university 
and year).  
 
12.11. Evaluation of a grant application  
Typical features of a poor grant proposal are carelessness, unrealistic proposal, unfo-
cussed proposal and “scientific whitewash”. Carelessness in preparing the proposal is 
usually shown as disregard for the instructions provided by the funding agency. Unre-
alistic and unfocussed are almost synonyms meaning that there is no way to complete 
the proposed research within the funding period or there are far too many research 
topics needing, for instance, 200 people and 20 years to complete the study. “Scien-
tific whitewash” simply means that the description of preliminary (unpublished) ex-
periments is greatly exaggerated and the conclusions are entirely unwarranted. It is, 
however, highly advisable to adhere to the truth as otherwise problems may be en-
countered in the context of the final reporting.  
 In principle, international panels of experts should be used to evaluate the propos-
als (the applications have to be written in English). The applicant should receive a 
written evaluation report. The research plan (and its feasibility) has to be considered 
as the most important part of the proposal and not the track record of the applicant. 
 The following is an authentic evaluation report of a grant proposal. As indicated 
in the evaluation form, the research plan occupies a central position, as it should, in 
the evaluation. The fact that most methods are already in the use in the laboratory is 
appreciated. Moreover, the report assesses the research environment and, exception-
ally, comments the financial situation of the applicant (an international grant is just 
about to expire). The high cost for animals and reasons for that are likewise under-
stood. Note that the application did not call for outside expertise. The training for 
graduate students and postdoctoral fellows is also commented. 
 The second part of the evaluation report contains the overall evaluation and the 
ranking of the application. The scores are from 1 (poor) to 5 (outstanding). In prac-
tice, funding agencies like the Academy of Finland mostly finance only outstanding 
and a few excellent applications. Note that a short explanation is provided for each 
score. 
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Below are the both parts of the evaluation report. The proposal apparently got funded 
by the Academy of Finland. 
  
12.12. Personal grant 
 The grant proposal is principally prepared according to the described format. De-
tailed budget, however, is unnecessary providing that funding agency does not require 
accounting. The agency mostly sends a notification of the grant to the local Internal 
Revenue Service Office (Tax Office). Currently, a person can receive personal grants 
worth about € 15,000 per year without paying taxes. 
 
12.13. Scientific writing and the society 
 Fig. 1 (page 7 ) depicted the place of an individual researcher in the internal proc-
ess of science. On the other hand, a scientist has a distinct role also in the interactions 
between science and society. Funding decisions made by the major agencies are usu-
ally public and it is possible that the media and general public become interested in a 
recipient of a substantial grant. In this case, an individual scientist may possibly gen-
erate marked public arousal. In the context of important scientific publications, a sci-
entist may give a press release describing the significance of his/her results. Public 
awareness is subsequently reached through the media. More seldom, an interesting 
publication is picked up from its original source leading to an interview of the scien-
tist and finally to the awareness of the general public. The extent of the publicity en-
PROPOSAL EVALUATION FORM CONFIDENTAL
Name of call: General application of research appropriations, May 2001
Name of applicant: Juhani Jänne
Title of proposed project: Activation of polyamine catabolism in
                     in transgenic rodents
Proposal number: 7787
1. Evaluation Criteria
1.1. Research plan:
This proposal aims to elucidate the cellular functions of the natural
polyamines using transgene disruption technology. The research plan
is concise and well organised with clear objective.
1.2. Scientific level and originality:
The scientific plan is adequate and the planned activities will provide
significant progress.
1.3. Research methods:
State of the art technologies will be used already existing in the laboratory.
1.4. Scientific merits and expertise:
The applicant has a long experience in the subject with a solid publication 
record with many recent articles. Some of which published in high impact journals.
1.5. Research environment:
a) Organisation:
The research team appears to be an effective use of resources taking advantage of
different areas of expertise. We not that the applicants NIH grant ends 2001. The
budget includes significant portion of animals (300 kFIM per year) during the 3-
year project for purchase of animals from outside breeders due to reconstruction
of the animals facilities that started May 2001.
b) National and international co-operation:
The majority of the research seems to be independent of outside expertise.
c) Training for graduate students and post-doc researchers:
Adequate
2. Overall evaluation and conclusions
2.1. What are the main strengths and weaknesses of the
       proposal? Possible remarks and recommendations.
+ ongoing research of good quality with a broad approach that
   is likely to succeed
+ established scientist
+ excellent proposal
2.2. Summary rating:
5 Outstanding proposal
4 Excellent proposal, which however contains minor
    elements that could be improved
3 Good proposal, which contains elements that could be
    improved
2 Average proposal, in need of substantial modification or
    improvement
1 Poor proposal, with severe weaknesses that are intrinsic 
   to the proposed project
 
x
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countering scientists, however, is modest in comparison with that of athletic celebri-
ties. This exemplified by the following story. A researcher was wondering about the 
extensive public attention and worship paid to the top athletes. His colleague burst 
out: “Who on earth would pay to see a scientist.” 
 Fig. 5 summarizes the role of an individual scientist in the interaction between 
science and society. 
                             Fig. 5. An individual scientist and the society 
 
 
13. The ethics of research 
 
 Research has its own ethical rules, the violation of which may even lead to crimi-
nal actions. Scientific work differs from many other civil activities in the sense that a 
researcher has a remarkable freedom to do his/her work. In many cases, it is exceed-
ingly difficult to verify the original experiments. The latter may lead to the temptation 
to exaggerate or even to falsify results. However, science effectively controls its own 
activities, as practically all observations will be repeated and verified. Experimental 
results that cannot be verified by others simply “die” and disappear from the scientific 
literature. Hence, there is no need to kill bad science as it will die by itself. In the twi-
light zone of good scientific practice, there are a number of bad procedures that are, if 
not condemnable, at least reproachable. “Salami science”, i.e. the experimental data 
are sliced to pieces that are called “the least publishable units”, distinctly belongs to 
the latter procedures. Unfortunately, this sort of practice is more rule than exception 
in the Nordic Countries, as doctoral theses have to contain a certain minimum of 
original publications leading to a fragmentation of research entities. A further exam-
Individual scientist Funding agency
Grant
proposal
Peer reviews
Media
Public
Articles
Presentations
Interviews
Newspapers
Magazines
Television
Radio
Articles of
general interestPublication
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ple is dual publication that, however, violates good scientific practice at the worst. 
Dual publication means that same experimental results will be published more than 
once. It is acceptable that the data have been presented at scientific meetings and pub-
lished as a meeting abstract in the proceedings but even this needs to be mentioned in 
the primary paper. In some rare cases, the same data can be published twice providing 
that the approaches are different and the original paper is properly cited. The use of 
same control material in several publications without a reference to the original paper 
is similarly forbidden. Entirely condemnable is to submit the same manuscript (or ex-
perimental data) simultaneously to two different journals. The possibility to get 
caught is substantial, as in highly specialized fields there are only a few competent 
reviewers and the two manuscripts may end up with the same reviewer. 
 
13.1. Violations of good scientific practice 
 The National Committee for Research Ethics has in 1998 defined the violations of 
good scientific practice essentially as listed below: 
1. Not giving appropriate credit to someone else´s work 
2. Inappropriate citing to published literature 
3. Misleading reporting of experimental results/methods 
4. Defective entry of experimental results 
5. Dual publication of experimental data 
6. Public misrepresentation of one´s own result 
 The two first violations are in all likelihood the most common, though it may dif-
ficult to define whether the practice has been condemnable or just reproachable. 
 The following is an authentic example of a quotation of literature without appro-
priate reference. Similarities between both texts have been bolded. It is noteworthy 
that the latter text contains identical references exactly in the same places as in the 
original text. The original text (2002) appeared in the Introduction section and latter 
text (2004) in the Discussion section. If not clear plagiarism, it is very close to it. 
Probably the most common form of plagiarism is “autoplagiarism”, meaning that the 
author carefreely cites his/her earlier text in a copy-paste manner. 
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Niiranen et al. (2002) J. Biol. Chem. 277, 25323-25328. 
 
   The oxidative catabolism of the higher polyamines spermidine 
and spermine is accomplished by the concerted action of two 
different enzymes, namely spermidine/spermine N1-acetyl-
transferase (SSAT)1 and polyamine oxidase (PAO). Cytosolic 
SSAT N1-acetylates both spermidine and spermine whereafter 
they serve as substrates for peroxisomal PAO (1). As PAO 
strongly prefers acetylated polyamines to the unmodified poly-
amines as its substrates, SSAT is generally considered as the 
rate-controlling enzyme in the back-conversion of spermidine 
and spermine (2). The final product of the …………. 
References 
(1) Hölttä, 1977  (2) Casero and Pegg 1993 
 
 
Chen et al. (2004) J. Cell Biol. 167, 161-170. 
 
   The oxidative catabolism of the higher order polyamines, 
spermidine and spermine, is accomplished by the concerted 
action of two different enzymes, SSAT and polyamine oxi-
dase (PAO). Cytosolic SSAT N1-acetylates both spermidine 
and spermine, which then serve as substrates for peroxisomal 
PAO (Holtta, 1977). Because PAO strongly prefers acety-
lated polyamines to unmodified polyamines, SSAT is gener-
ally considered the rate-controlling enzyme in the back con-
version of the higher order polyamines, spermidine and sper-
mine, to the lower order polyamine, putrescine (Casero and 
Pegg, 1993). 
 
 
 
13.2. Scientific fraud 
 The following malpractices distinctly fulfill the criteria for scientific fraud: 
1. Data fabrication 
2. Misrepresentation and falsification of data in such a way that the results based 
on observations will change 
3. Misappropriation of somebody’s original idea, research plan or observations 
4. Plagiarizing somebody’s research plan, manuscript, article or other text or part 
of it 
As indicated, violations of good scientific practice apply to scientific publication and 
grant proposal as well. 
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13.3. Procedures in suspected scientific fraud 
 National Committee for Research Ethics has given clear instructions on how to 
proceed in case of suspected fraud (summarized in Fig. 6). An example could be a 
situation where a collaborator has not been included as an author although he/she had 
centrally contributed to the results of the publication. When scientific fraud is sus-
pected, a formal letter describing the case is sent to the Rector of the University of the 
suspect (or to the Director of a Research Institute). The Rector or the Director decides 
whether a preliminary hearing is needed. If the Rector or Director decides that a pre-
liminary hearing is not necessary, the case will be cancelled. However, if the plaintiff 
is not satisfied with the decision, he/she can bring the case to the National Committee 
for Research Ethics and ask for an opinion.  
       Fig.6. Procedures in suspected scientific fraud 
  
 A decision of preliminary hearing has to be reached in 60 days. During the pre-
liminary hearing, the suspect is interrogated and the plaintiff will be informed about 
the hearing. The decision of a possible hearing has to be reached in 120 days. The 
hearing is carried out by experts in the particular field of research. After the hearing, 
the experts produce a final report, which is an official document. Depending on the 
results of the hearing, the case is either cancelled or further actions are taken. The ac-
tion may be a publication in the same forum (retraction) or civil servant or even 
criminal procedure. It is noteworthy for those unsatisfied with the results, that the Na-
tional Committee for Research Ethics can be contacted at any stage of the procedure. 
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The Committee can return the case to the appropriate Rector or Director for further 
investigation. 
 The number of cases of scientific fraud in Finland has been very low, but as the 
competition is all the time tightening up, it is expected that at least milder cases are 
showing up and hence one should be prepared to react properly. 
 
14. Further readings 
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